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Abstract 
Resulting from a high degree of sequence variability, a few human light-chains 
have a propensity to form amyloid fibrils. The monoclonal V J6 proteins are involved in 
fibril formation resulting in amyloidosis (AL). A previous study of a· patient (Jto) with 
multiple myeloma in whom the V J6 protein was deposited in the form of renal tubular 
casts was shown to form fibrils very slowly. The slow fibril formation resulted from the 
improved thermodynamic stability gained from an extra salt-bridge between Asp 29 and 
Arg 66B. To further investigate the effect of this interaction, two mutants Asp 29 to an 
Ala (JtoD29A) and Arg 66B to a Ser (JtoR68S) that disrupts the salt-bridge were made. 
Interestingly, the JtoD29A and JtoR68S have very different kinetics of fibril formation. 
The JtoD29A forms fibrils very slowly, while the JtoR68S forms fibrils at a rate similar 
to the pathogenic V).6 Wil. In this study we have crystallized JtoD29A and JtoR68S in the 
same space group P4 122 with the same cell dimensions and solved their X-ray structures 
to 1.6 A and 1.9 A resolution, respectively. Structural comparisons reveal that although 
there are no significant main-chain conformational changes, there are several side-chain 
conformational changes due to the mutations. These differences contribute to JtoR68S 
having a larger exposed hydrophobic solvent surface as compared to JtoD29A. The Arg 
to Ser mutation in JtoR68S is also responsible for its increased negative electrostatic 
potential as compared to JtoD29A. We have also attempted to trap a pH induced 
structural intermediate of JtoR68S. While these findings are preliminary and need to be 
further investigated, these methods provide new means and insights for studying the 
amyloid phenomenon. 
ii 
Table of Contents Page 
Chapter 1: Background and Introduction 1 
Amyloid Hypothesis 2 
In Vitro Fibril Formation 4 
Probing T�e Primary Structure For Amyloidogenic "Hot Spots" 8 
Light Chain Amyloidosis 12 
Organs Affected By Light Chain Amyloidosis 12 
Fibrils And Casts 13 
Light Chain Variable Domains 14 
Three-Dimensional Structures 15 
The Jto And Wil Structures 15 
Aim of this work 19 
Chapter 2: Methods 22 
Expression And Purification Of JtoD29A And JtoR68S 22 
Crystallization Of JtoD29A And JtoR68S 22 
X-ray Diffraction 26 
Data Collection 3 0 
Determination of Structure 3 0 
Molecular Replacement 30 
Deriving Matthews Volume 36 
Translation Function 36 
111 
Refinement Of The Structures 38 
Conjugate Gradient Refinement 41 
Maximum-Likelihood Method 41 
Simulated Annealing 42 
Hydrophobic Surface Area Calculation 44 
Difference Distance Matrix Plots 45 
Electrostatic Surface Area Calculations 46 
Chapter 3: The High Resolution Structures of JtoD29A and JtoR68S at pH 5.0 48 
Crystallization Of JtoD29A And JtoR68S 48 
Data Collection And Processing 49 
Structure Determination Of The JtoD29A And JtoR68S Mutants 50 
Refinement Of JtoD29A And JtoR68S 5 l 
2Fo-Fc Omit Maps For JtoD29A And JtoR68S Mutants 53 
Comparison of the main-chain conformations of Jto, JtoD29A, 
JtoR68S, and Wil 53 
Side-Chain Conformational Analysis 56 
Comparison Of Hydrophobic Surface Areas 58 
Electrostatic Potential Surface Analysis 63 
Side-Chain Differences Observed In Wil Compared To The Jto Structures 65 
Chapter 4: Determination of the structure of JtoR68S at pH 4.0 and pH 3.0 68 A. JtoR68S Crystals Incubated At pH 4. 0 68 
B. JtoR68S Crystals Incubated At pH 3.0 71 lV 
Chapter 5: Conclusions and Future Directions 
A. The JtoD29A And JtoR68S Structures 
B. Low pH Soaks Of JtoR68S Crystals References Appendix Vita V 75 75 76 78 82 128 
List of Figures Page 
Figure 1.1. Fibrillogenesis assay of two V,.,6 light chain antibodies, Jto and Wil. 3 
Figure 1.2. The model by Sunde and Blake of the generic amyloid fibril. 5 
Figure 1.3. Three pathways are present that the native protein may take when forming an aggregate. 6 
Figure 1.4. Diagram of the V,.,6 light chain antibody. 9 
Figure 1.5. Cartoon diagram of the regions that compose an antibody. 11 
Figure 1.6. All known light chain variable region structures. 16 
Figure 1.7. The new ionic interaction found in Jto between aspartic acid 29 and arginine 68. 18 
Figure 1.8. Fibrillogenesis of the V,.,6 proteins. 20 
Figure 2.1. A two-dimensional lattice showing the a and b axes. 23 
Figure 2.2. The fourteen Bravais lattices representing the seven crystal systems and the accounting for centering of lattice points. 25 
Figure 2.3. Stereographic projection of space groups. 27 
Figure 2.4. Scattering of X-rays at two planes. 29 
Figure 2.5. Eulerian angles a,�' y used in rotational search. 33 
Figure 2.6.- The rotation and translation functions for the JtoR68S structure. 35 
Figure 2.7. The refinement protocol used to refine both the JtoD29A and the JtoR68S structures. 43 
Figure 3.1. 2Fo-Fc omit maps generated at the site of the mutation for (A) JtoD29A model shown at the mutation site, D29A, and (B) the JtoR68S model shown at the mutation site, R68S. 54 
Figure 3.2. Main-chain Ca superposition of Jto (gray), JtoD29A (green), JtoR68S (red), and Wil (Blue) using the program LSQMAN implemented in 0. 55 Vl 
Figure 3.3. Superposition of Jto (white), JtoD29A (green), and JtoR68S (red) around the sites of mutations, residues 29 and 68. 57 
Figure 3.4. A comparison of accessible apolar surface area between JtoD29A and JtoR68S. 60 
Figure 3.5. Difference Distance Matrix Plots were calculated using the program DDMP (DDMP ). 62 
Figure 3.6. Electrostatic potential surface for (A) Jto, (B) JtoD29A, (C) JtoR68S were calculated using the program Delphi (Rocchia, Alexov et al 2001). 64 
Figure 3. 7. Vast side-chain conformational differences are observed in Wil when compared to the Jto, JtoD29A and JtoR68S structures resulting from seventeen amino acid variations in the Wil amino acid sequence. 67 
Figure 4.1. 2Fo-Fc electron density map shown with the model of the JtoR68S structure at CDR3 after one round of positional refinement in CNS. 72 
Figure 4.2. Modeling of the CDR3 region. 74 vii 
Chapter 1: Background and Introduction The aggregation of normally soluble protein into fibrils is known as amyloidosis. The formation of these aggregates contributes to the disease state of several neurodegenerative diseases such as: Alzheimer's, Parkinson's, Hunington, Type II Diabetes, and L-chain associated amyloidosis (AL) (Delabar, Goldgaber et al. 1987) (Kruger, Eberhardt et al. 2002) (Jaikaran and Clark 2001) (Cardoso, Merlini et al. 2003) (Solomon, Frangione et al. 1982). Alzheimer's disease results from an accumulation of extracellular amyloid plaques accumulating in the central nervous system. The plaques result from a cleavage and secretion of Amyloid Precursor Protein (APP), which then propagates the formation of fibrils (Temussi, Masino et al. 2003). The fibrils form plaques around the nervous tissue and result in tissue death. Parkinson's disease is linked to intracellular amyloid fibrils resulting from intracellular aggregation of Transthyretin in the part of the brain responsible for control of motion, the substantia nigra. Accumulation of the fibrils destroys the neural tissue and leads to a loss in control of motion (Krishnan, Chi et al. 2003). AL is characterized by the deposition of aggregates composed of L-chain variable regions (V L) in the kidneys, heart, and peripheral nervous system as amyloid fibrils. Wide-ranging effects occur from these depositions including loss of cellular functionality, tissue breakdown, and death. Patients with multiple myeloma, which is characterized by the overproduction of monoclonal L-chains, are linked to the development of AL. However, only as few as 10-15% multiple myeloma patients develop the AL disease. Each amyloid disease differs in the pathological effects and the protein pre-cursors that lead to the tissue specific formation of amyloid fibrils (Bellotti, Mangione et al. 2000). The wide-ranging deleterious effects from amyloid 1 
disease have promoted a great deal of research to determine the mechanism in which a native protein aggregates into an amyloid fibril. It is apparent from recent work that the propensity to form amyloid fibrils results from both environmental conditions and variation of amino acid sequence leading to thermodynamic destablization. 
Amyloid Hypothesis The main step in the manifestation of amyloid disease is the conversion of normal, natively folded proteins into aggregates that are composed of mostly J3-pleated sheets, which assemble into the amyloid fibril. Traditional hypothesis states that this unfolding event is driven by the relative stability of the native protein. Destabilization of . the native fold will produce a partially unfolded intermediate, which becomes the nuclei responsible for the formation of the amyloid fibril. The process of destabilization of the native state is known as the lag phase (see Figure 1.1). The lag phase represents the time to form the nuclei. After the nucleus is formed, large polymers begin to grow at a rapid . rate producing the fibril (Merlini, Bellotti et al. 2001) (Soto 2001) (Lansbury 1999) _. · . (Rochet and Lansbury 2000). As the fibrils grow they adopt a cross-J3 pleated structure, which was determined by X-ray fiber diffraction (Sunde and Blake 1997) (Sunde, Serpell et al. 1997). Cohen and Calkin produced the first structural data pertaining to the amyloid fibril in 1959 (Cohen and Calken 1959). The structure of the fibril was ascertained from X-ray fiber diffraction studies on amyloid plaques isolated from amyloid diseased patients. This structural study only indicated that the amyloid plaque was of a fibrillar 2 
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Figure 1.1. Fibrillogenesis assay of two V,.,,6 light chain antibodies, Jto and Wil. Notice that the non-amyloidogenic Jto has a much longer lag time than the amyloidogenic Wil. 3 
nature (Cohen and Calken 1959). However, in 1967 the principle structure of the amyloid fibril was solved by electron microscopy (Shirahama and Cohen 1967). Utilizing fibrils isolated from light chain amyloidosis patients, Shirahama and Cohen found that a fibril ranged from 75-80A in diameter. Each fibril was composed of 5-6 smaller repeating units known as protofilaments. The protofilaments are a smaller fibrillar unit arranged parallel to each other. Each protofilament · appeared to be approximately 25-25A in diameter. Each protofilament was found to be composed of three other subunit strands known as sub-protofilaments. Each sub-protofilament strand was between 10-15A in diameter, and the group of strands was arranged helically and repeated every 35-50A (see Figure 1.2). It was apparent from these studies that each amyloid fibril was composed of highly ordered structural repeats (Shirahama and Cohen 1967). It later became evident that each fibril adopted structural elements similar to the initial structures described by Shirahama and Cohen independent of the identity of the protein composing the fibrils (Cohen, Shirahama et al. 1982). As mentioned before, the traditional hypothesis states that the native state of the protein must be destabilized to initiate fibrillogenesis. Although the event that leads a protein to form ·a fibril has been rigorously studied over the past years, the mechanism of fibril formation is still- unknown. Moreover other aggregates may be obtained instead of the amyloid fibril (Figure 1.3). 
In Vitro Fibril Formation It has been proposed that any protein will form fibrils if presented with the correct environmental stimuli. These stimuli would include lowering or increasing the pH, salts, 
4 
Figure 1.2. The model by Sunde and Blake of the generic-amyloid fibril. A number of P-sheets ( four shown here) comprise the pro to filament. These sheets run parallel to the axis of the protofilament. Normal twisting of the sheet of the sheet results in result in a common helical axis giving a helical repeat of 115.5A containing 24 P-sheets (Shirahama and Cohen 1967).-
5 
Native Protein 
Amorphous Casts Amyloids Fibrils Crystals Figure 1.3. Three pathways are present that the native protein may take in forming an aggregate. The cast is characteristic of Light Chain Deposition disease and appears as amorphous clumps in the kidneys. Crystals may also form in the kidneys and result in Fanconi syndrome. The third aggregate is the amyloid fibril. 6 
and other denaturant such as urea (Dobson 1999). The first case is the small a-helical protein acylphosphotase (Chiti, Webster et al. 1999). Chemical denaturing experiments with the denaturant trifluorethanol (TFE) indicate in vitro that a total unfolding of the protein perturbs the formation of fibrils. However, a slight denaturation of the structure over time will facilitate the formation of amyloid fibrils. This indicates that only a partial denaturation or rearrangement of structure is required to form fibrils (Chiti, Webster et al. 1999). A second study by Dobson's group used the SH3 domain of the P85a. subunit of phoshpotidylinositol 3-kinase, which has not been associated with any amyloid disease, for study of fibril formation (Bucciantini, Giannoni et al. 2002). Even though the SH3 domain is not related to amyloid fibrils in vivo, in vitro the protein could be induced to form fibrils by incubations in low pH buffer. When proteins linked to amyloid disease were used for in vitro fibril assays, heterogenous mixtures of the proteins in different folded states were found (Khurana, Gillespie et al. 2001 ). Interestingly the SH3 domain, which is not linked to amyloid disease, had a uniform conformation at pH 5.0, which forms amyloid fibrils after several days of incubation. This shows that it is possible to study the unfolding pathway, which leads to the formation of fibrils, in vitro and lowering the pH of the proteins environment can induce formation of the nuclei (Bucciantini, Giannoni et al. 2002). A third study by Dobson, which used the amyloidogenic J32-Microglobulin protein, detected two partially folded intermediates that eventually formed amyloids (Chiti, Mangione et al. 2001 ). The study found that high concentrations of the proteins were not sufficient to form amyloid fibrils. However, incubation in chaotropic denaturants enabled the group to isolate the intermediates. Total unfolding was discovered at 3.0M Guanadine HCL. The partially unfolded intermediates were found 
7 
between O.IM and I.OM Guanadine HCL. These findings further show that fibril formation can be induced by perturbing the structure of the protein and that intermediates are formed along the particular unfolding pathway that leads to the formation of the amyloidogenic nuclei (Chiti, Mangione et al. 2001). Anthony Fink's group applied Chris Dobson's idea of chemical perturbation of protein structure in forming amyloid fibrils to the study amyloidogenic light chains (Khurana, Gillespie et al. 2001). In this study Fink's group utilized the V,A LC SMA to isolate partially unfolded intermediates by incubation in low pH buffers. Two intermediates were isolated. The first intermediate occurred at pH4, which resulted in forming amorphous casts. Amorphous casts are lesser aggregates that contribute to the Light Chain Deposition Disease (LCDD), which has a lower pathogenicity as compared to amyloidosis. A second intermediate was found at pH2. This intermediate led to the formation of amyloid fibrils (Khurana, Gillespie et al. 2001). This study shows that lowering the pH of the light chains environment can lead to the formation of intermediates along the amyloidogenic unfolding pathway (Khurana, Gillespie et al. 2001). 
Probing The Primary Structure For Amyloidogenic "Hot Spots" Several groups have studied the role of amino acid substitution in fibril formation. Through sight directed mutagenesis, Fred Stevens' work has shown several critical residues in V ,A light chains, which play a role in the formation of amyloids (Figure 1.4). (Stevens 2000). Stevens' group found that the mutation of a neutral glutamine residue at position 89 to an Asp increased the propensity for a V ,A LC protein LEN, to form fibrils 
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Figure 1.4. Diagram of a V').,6 light chain antibody. Nine 13-strands, FW l,2,3a&b,4-7, compose the framework of the protein. The three complementary determining regions, which compose part of the antigen recognition motif, are shown in green. 9 
(Pokkuluri, Gu et al. 2002). The increase in negative charge contributed by the Asp89 was proposed to destabilize the structure of LEN. Moreover, the study shows that a structurally related protein, Myelin Protein Zero (MPZ), contains Asp99 in an equivalent position that is involved in an ionic interaction with Arg38. The ionic interaction in MPZ contributes to stability and impairs fibril formation (Pokkuluri, Gu et al. 2002). Ron Wetzel's group has found that amino acid replacement in the �-framework (the scaffold of the light chain, see figure 1.4), results in the formation of fibrils (Hurle, Helms et al. 1994). Destabilization of the protein framework is achieved by amino acid substitutions, which disrupt the �-strand formation in the framework leading to a destabilized native fold and the propensity to form fibrils. However, Wetzel's group has also noted that amino acid substitutions in the antigen recognition loops of the light chains also increase amyloidogenesis (Helms and Wetzel 1996). Interestingly, the antigen recognition loops (CDRs) in the light chains are hyper variable and are normally not involved in structural stabilization. This indicates that amino acid substitutions at almost any region of the molecule can affect fibrillogenesis. The nature of light chains promotes them to naturally undergo rapid substitutions in their amino acid sequence. Only a few light chains are able to form amyloid fibrils. Apparently, particular somatic mutations leads to fibrils (Raffen, Diekman et al. 1999). The comparison of non-amyloidogenic light chains to amyloidogenic light chains allows for comparison of structural properties leading to formation of amyloid fibrils. A great deal of work is now presented which attempts to explain what parts of a native light chain (Figure 1.5) promote the formation of the amyloid fibril. 
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Figure 1.5. Cartoon diagram of the regions that compose an antibody. An antibody is composed of two types of chains: the heavy and the light chain. Both chains are divided into constant and variable regions. The variable region undergoes recombination at a rapid rate during B cell selection. The light chain variable region is the region that contributes to light chain amyloidosis. 
11 
Light Chain Amyloidosis Light chain amyloidosis results from a deposition of amyloid fibrils composed of the variable region of monoclonal immunoglobulins light chains. This particular type of amyloid disease distinguishes itself from other amyloid diseases by several means. First, the immunoglobulin light chain is derived from an expanding clone of rapidly differentiating B cells where the variable region (V L) of the light chain is highly mutated when compared to the germline gene. The consequence of the rapid differentiation results in a heterogenous pool of light chain variable region immunoglobulins. The wide variety of V L have provided both a helpful system to study the phenomenon of amyloid fibril formation and a hindering wealth of proteins that may follow differing paths in forming the amyloid fibril. Second, the progression of the disease and the organs in which the disease manifest is reflective of the light chain involved. Some light chains do not form amyloid fibrils, but instead opt to form a lesser-ordered aggregate known as a cast. These casts result in LCDD, which has a decreased pathogenicty as compared to amyloidosis. Since it is apparent that the light chain has several paths to choose, of which different ends are achieved, the choice of path relies on the sequence of V L light chain and ultimately the structure produced by that sequence (Bellotti, Mangione et al. 2000). 
Organs Affected By Light Chain Amyloidosis Light chain amyloidosis fits into both the primary and secondary category of amyloid disease. Primary amyloidosis results in the formation of amyloid fibrils without 
12  
any previous presence of disease, which may account for the presence of the plaque. Secondary amyloidosis results from a primary disease other than an amyloidosis, which produces amyloid fibrils as a secondary product. Development of amyloidosis in multiple myeloma patients is an example of secondary amyloidosis. With each form of amyloidosis, particular organs are targeted for the formation and accumulation of amyloid fibrils. In primary amyloidosis, the heart, lung, skin, tongue, thyroid gland, and intestinal tract may be involved. Localized amyloid plaques may also be found in the respiratory tract or other sites. Frequently the liver, spleen, kidney and the vascular system, especially the heart, are involved. Secondary amyloidosis shows a preference for the spleen, liver, kidney, adrenals, and lymph nodes. However, alL organ systems are linked to �he disease and vascular involvement may become widespread. The liver and spleen are often enlarged, firm, and rubbery. Fibril deposition in the kidneys can also result in an enlargement of the organs (Solomon, Weiss et al. 1992). �nterestingly, amyloidosis is not the only light chain associated aggregate disease found in the kidneys. The kidneys also appear to accumulate other lesser-ordered aggregates composed of light chain VL regions resulting in LCDD and Fanconi syndrome. 
Fibrils And Casts Approximately one third of all primary amyloidosis patients possess fibrils in the kidneys. Localization of the fibril in different parts of the kidney is not seen. However, the glomerulus appears to be the primary site of fibril accumulation. Along with fibrils, the kidneys also accumulate light chains in the form of casts, which are disordered precipitates of the proteins. The casts represent another disease known as Light Chain 13  
Deposition Disease (LCDD). Solomon and co-workers have reported the various aggregation phenomena associated with the kidneys(Ozaki, Abe et al. 1994). Chris Dobson and co-workers have reported that light chains can be coerced to form fibrils by environmental stimuli. Solomon's group observed that renal concentrations of urea varied depending on the area of the kidney and condition of the kidney's health. Moreover, they found with the V KL SMA and LEN fibrillogenesis could be induced by incubation in concentrations (µM) of urea that were physiologically similar to that found in the kidney. He also found two kidney osmoloytes, betaine and sorbitol, which counteracted the effects of urea. While urea destabilizes the compact state of the native protein by binding to the surface of the protein and decreasing the solvent exposed surface area, these osmolytes are excluded from the protein surface and promote a tighter packing of the native state. Solomon and co-workers have suggested that relative concentrations of these solutes acted as a control mechanism, which would either promote or perturb the formation of amyloid fibrils (Ozaki, Abe et al. 1994). 
Light Chain Variable Domains Two classes of V L antibodies exist: the V K and VA classes. Both classes are linked to amyloid disease. However, the most prevalent class associated with amyloid disease is the VA light chains. In a study of 35 light chain amyloidosis patients, 77% of the group contained fibrils composed of VA light chains (Bellotti, Merlini et al. 1990). Interestingly, another group performing a similar study with a large field of patients noted that approximately 50% of all LC amyloidosis patients contained fibrils composed of the 14 
V ,.6 subgroup of the V,., family (Solomon, Frangione et al. 1 982). Moreover, all but one isolated V ,.6 light chain resulted in light chain amyloidosis. The V 1( and V,. classes of light chains differ in structure. The noticeable difference between the V,. and the V 1( classes occurs at framework 3. In the V ,._ class, an insertion occurs at this region, which results in the addition of two new frameworks strands, 3a and 3b. However, even with this insertion the overall native structure of both classes is very similar, as can be seen in Figure 1.6. 
Three-Dimensional Structures The light chain variable region is composed of anti-parallel P-sheets. The P­strands composing the framework of the protein are connected by loops. Three of these loops compose the complementary determining region (CDR). The CDRs of a light chain variable region and a heavy chain variable region comprise the antigen recognition motif of the antibody. Sequences of the CDRs are highly variable between each light chain and these regions are the sites of rapid recombination during B cell maturation. A diagram of a V,.6 light chain can be seen in Figure 1 .4. Shown here are all known structures of V 1( and V ,._ light chains. It is easy to see from the diagram that the global structure of the proteins is relatively the same. 
The Jto And Wil Structures The Jto and Wil V ,.,6 light chains were isolated from two patients, Jto and Wil. Wil was a classical amyloidosis patient, who secreted a high amount ofV,.6 light 15 
K4 Rei JtoD29A Bre JtoR68S 
Figure 1.6. All known light chain variable region structures. On the left are the V->.6 structures, while the V ,A structures are on the right. -Notice that all adopt a similar global structure. 16 
chains in the urine. The patient Jto also secreted a high amount of V,.6 light chains in the urine, but did not develop amyloidosis. Instead this patient developed renal casts characteristic of the lesser pathogenic light chain deposition disease. This presented an exceptional chance to study the V')..6 light chains, since the Jto light chain was the only isolated V ,.6 light chain that did not form amyloids in the patient. The genes for Wil and Jto were both isolated, and the proteins were expressed recombinantly in E. coli. Fibrillogenesis assays performed on the two showed that Jto would form fibrils in vitro, but these fibrils occurred very slowly as compared to the pathogenic Wil (Figure 1.1 ). Even though the two proteins differed in their rates of fibril formation, the stability of the two proteins was negligible as the the Tm of Jto was 45.2°C and the Tm of Wil was 38.3°C (Wall, Schell et al. 1999). To determine the factors contributing to this stability, the X-ray structures of both Jto and Wil were solved (Pokkuluri, Solomon et al. 1999). The two structures were relatively superimposable with an rms deviation of the Ca atoms of approximately 0.8 A. However, a difference was found in the region of CDR-2, which was an unusual arginine at position 68 in this loop. This Arg68 formed a new ionic interaction (Figure 1.7) with an aspartic acid at position 29 (see Figure 1.7). This new ionic interaction was hypothesized to be the stabilizing factor in Jto, which prevented the patient from developing amyloidosis. To further study this new ionic interaction, two mutants of Jto were made: JtoD29A and JtoR68S. In both mutants, the acid (JtoD29A) and the base (JtoR68S) are 
17 
Asp29 Arg68 
Figure 1.7. The new ionic interaction found in Jto between aspartic acid 29 and arginine 68. 18 
mutated back to the germ line residue. Not surprisingly both the JtoD29A and JtoR68S exhibited superimposable unfolding curves with Tm around 42°C (see Figure 1.8a). However, they had different kinetic properties of fibril formation (see Figure 1.8b ). JtoR68S was a fast fibril former occurring at a rate comparable to Wil. On the other hand, the JtoD29A formed fibrils at a rate slower than Jto (Gupta, Wilkerson et al . 2003). Since these two mutants differ by only one amino acid substitution and possess such differing rates of fibril formation while maintaining similar stabilities, the structure of the two proteins is sought. 
Aim Of This Work The work presented here involves the crystallization and structure determination of the JtoD29A and JtoR68S proteins. The properties of the native state dictate the speed of fibrilogenesis. Thus determination of the native structure of an amyloidogenic protein can allow for elucidation of structural characteristics promoting fibrilogenesis. For this reason we have solved the structures of the JtoD29A and JtoR68S proteins. Coupled to this we would also like to determine the structure of intermediates along the pathway to form amyloid fibrils. It has been shown that decreasing the pH of the buffer containing amyloidogenic proteins resulted in the capturing of intermediates (Chiti, Mangione et al. 2001 ). We also attempted to trap a structural intermediate of the JtoR68S mutant by incubation of crystals in low pH buffers. We hypothesize that the constraints placed on 19 
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Figure 1 .8. Fibrillogenesis ofY�.6 proteins: Folding stability and kinetics (A) Protein unfolding curves (fluorescence intensity of Trp35 at 350 nm) (B) Fibril formation (PBS, pH 7 .5, 3 7° C (increase in fluorescence emission of thioflavin T at 490 nm [ excitation = 450 nm]) T,  VA6Wil; o, JtoD29A; •, JtoR68S; ✓, VA6Jto. 20 
the structure by the crystal packing forces may prevent a total unfolding of the protein. 
Instead the crystal may preserve an intermediate without breaking the crystal. These 
structures should be highly useful for two reasons. First, the structures of the JtoD29A 
and JtoR68S will allow us to better understand what drives a V,.6 protein to form amyloid 
fibrils. Second, the structures of intermediates from pH denaturing will gives us insight 
into what occurs structurally on the path to forming the nuclei for amyloid fibrils. 
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Chapter 2 :  Methods 
Expression And Purification Of JtoD29A And JtoR68S The original cDNA encoding the V,,_6 Jto protein was isolated from an enriched population of bone marrow cells from patient Jto with multiple myeloma and sub-cloned into a pET-29( +) vector for protein expression in E. coli cells. The procedure for cloning, protein expression, and purification of both V,,_6 Jto and V,,_6 Wil are described elsewhere. The JtoD29A and JtoR68S mutations were constructed by use of the Stratagene Quick­Change site-directed mutation kit. Oligonucleotides containing the appropriate bases changes, D29A and R68S, were used to PCR amplify the V,,_6Jto/pET-29 plasmid. The template plasmid was digested with the Dpnl nuclease. The daughter plasmids were transformed into DH5a E. coli for plasmid production. The mutant V,,_6 proteins JtoD29A and JtoR68S proteins were re-transformed for protein production in E. coli as previously described. Recombinant proteins were subsequently purified by nickel affinity chromatography utilizing Nickel-NTA sepharose from Qiagen. All proteins were expressed and purified by our collaborator John Wahl at the University of Tennessee Medical Center. 
Crystallization Of JtoD29A And JtoR68S A protein crystal consists of a highly ordered lattice (Figure 2.1 ). The protein is arranged in a three-dimensional array known as the crystal lattice shown in Figure 2.1. The figure is a two-dimensional lattice representing the a and b axes. If one point in the lattice is moved one repeating unit along either axes it has moved to the adjoining unit 22 
(a ) 
(b) 
Figure 2.1. A two-dimensional lattice showing the a and b axes. A translation of one unit along either the a or b axis will result in a cell identical to the starting cell. Notice that the y angle sits between the a and b axes. The combination of the a and b axis with the c, which is coming out of the plane of the page, defines the unit cell. Figure taken from Ladd and Palmer (Ladd and Palmer 1985) 
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cell. The combination of the a and b axes with the third axis, c, gives the unit cell. The unit cell is the smallest repeating unit, which is defined by its three cell edges ( a, b and c) and the three angles formed from the cell edges ( a, �, and y). There are fourteen different classifications of unit cells known as Bravais Lattices (shown in Figure 2.2). The Bravais Lattice can be understood as the three-dimensional stacking of nets composed of lattice point. There are seven crystal classes unequally represented by the fourteen Bravais Lattices. These seven are: triclinic, monoclinic, orthorhombic, tetragonal, trigonal, hexagagonal, cubic. The crystal systems are defined by the lengths of a,b,c and angle of ex., p, and y. Each crystal system is then further classified by the placement of lattice points. These classifications are P, C, I, and F. P, or Primitive, is defined as a unit cell composed of one lattice point. The C stands for C-centering, F stands face-centering, and I for body-centering. (Ladd and Palmer 1 985). The smallest repeating unit in the unit cell is known as the asymmetric unit, which can be a motif of a protein or the entire molecule of the protein. The molecules within the asymmetric unit can arrange around symmetry elements resulting in further classification of the unit cell. Thirty two symmetry classes define the thirty two point groups. These elements are 2-, 3-, 4-, and 6- fold symmetry elements. Other symmetry elements that exist are mirror planes, glide planes, and centers of inversion. However, these do not occur in protein crystal as all naturally occurring amino acids are of the L conformation. 
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Figure 2.2. The fourteen Bravais lattices representing the seven crystal systems and the accounting for centering of lattice points. P is primitive, C is two-faced centered, F is all face centered, and I is body centered. Figure taken from Ladd and Palmer (Ladd and Palmer 1 985). 
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The combination of the fourteen Bravais Lattices and thirty-two point groups result in 230 space groups. Protein that crystallizes in the space group P4 122, where P represents the primitive Bravais lattaice, 4 1 represents the tetragonal crystal system with a 4 1 -screw axis of symmetry parallel to the c axis, and 2-fold symmetry axis parallel to a and b. The P2 1212 1 space group has a 2-fold symmetry along all three axis which defines the orthorhombic crystal systems (Ladd and Palmer 1985). A diagram of both space groups is shown in Figure 2.3 .  
X-ray Diffraction X-rays propagate at wavelengths on the order 1 - 10  A, which are suitable for diffraction experiments of protein crystals .  Normally X-rays at wavelengths between 0.5 and 1 .6 A are used. X-rays with wavelengths in this range will be scattered by electron clouds of atoms of similar size to the wavelength. Thus, X-rays on the range of 1 .5 A, the distance of a carbon-carbon bond will be useful for the study of protein structures. Unlike microscopy, where light is reflected off of a sample and then focused with a lens, X-rays cannot be focused by a lens to produce an image. However, the X-ray diffraction pattern of a crystal is its fourier transform, which can be deconvoluted to obtain the three­dimensional structure of the protein. X-ray diffraction is described Bragg' s  Law as follows: nA = 2d sin8 ( eqn 1)  where A is  the wavelength of the X-ray n is the order of the Bragg reflection 26 
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Figure 2.3. Stereographic projection of space groups. Shown is P212121 (A) space group and P4122 (B) space group. A + denotes that the point lies above the plane of the page, while a - denotes that a point lies below the plane of the page. Figure taken from the International Tables for Crystallography, Volume 2. 27 
8 is the angle of diffraction from the incident X-ray beam As shown in equation l ,  as the angle of 8 approaches 90° the resolution gets higher, characteristic of a small d value. The Bragg equation allows one to make the relationship between the reciprocal space (the diffraction pattern) and real space (see Figure 2 .4). Though this method is a simple method for the evaluation of a protein crystal, it is not sufficient for determining the structure of the protein (Ladd and Palmer 1 985). X-rays are characterized as photons with wave-like properties. Therefore X-ray diffraction is caused by interference of waves. Now the wave equation resulting from X­ray diffraction can be written as: F(x) = Fcos21t (hx + a) (eqn 2) where F(x) is the vertical height of the wave at any horizontal position x F is the amplitude h is the frequency of the wave a is the phase As shown from this equation a wave is characterized by the amplitude of the wave (F) and the phase. The diffracted X-ray is a complex wave resulting from the sum of all diffracted waves coming from the each atom in the crystal. This sum of waves is called a Fourier series. Further derivation will give us the structure factor equation: F(h,k,l) = nLj- 1fj e 27tl (hx+ky+tz) (eqn 3) where F(h,k,l) is the three-dimensional structure factor that describes the reflection 
0:Ej is summation of all atoms, j .  fj is the scattering factor for the j1h atom. 
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d sin�sinO Figure 2.4. Scattering of X-rays at two planes. The extra path for X-rays scattered at the second plane is 2d sine, as per Bragg's Law. 
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x+y+z are the positions of atom j in the unit cell. Performing a fourier transform on one will result in the other. Thus using the amplitude and the phase we can derive the electron density map of the unknown molecule. 
Data Collection The first step in structure determination is to collect a diffraction data set. Data is collected by oscillating the crystal to obtain maximum coverage of reciprocal space. For tetragonal crystals 90 degrees of data is required. The position of the reflections will be recorded as well as the intensities of each spot. The intensities are inversely proportional to amplitudes. In processing the data the intensities are scaled together. Usually to improve statistics a high redundancy of data is collected (Ladd and Palmer 1 985). 
Determination of structures To solve the wave equation (equation 2) we need both the amplitude and the phase. The amplitude is obtained from the data, as mentioned above. However, the data gives no information about the phase. This is known as the "phase problem". To determine the three-dimensional structure the phase problem has to be solved. The Molecular Replacement method is one such method that can be employed to solve the phase problem. 
Molecular Replacement Molecular Replacement uses a known structure to provide phase information for the data of the unknown structure. If a known structure is to be used, then it must be 
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homologous to the experimental protein whose structure is being solved. The known structure is referred to as the search model. Examples of this are wild-type proteins being used as search models for mutants or a homologue of the target protein. The program AMoRe implements the Molecular Replacement method (Navaza 1 994). The first step of AmoRe (Navaza 1 994) is to transform the search model from x,y,z data to Fourier coefficients representing the amplitude and phase. Next the amplitudes of the search model will be used to search against the known amplitudes found in the data. This is a two-step process, which involves a six-dimensional search. The first step is to locate the orientation of the target molecule by solving the rotation function. As stated before to solve the structure from an X-ray diffraction, one must know the amplitude and the phase of the diffracted X-rays. The intensity of a diffraction spot is proportional to amplitude of the wave. However, the phase is not given by the experimental data. In 1 934, Lyndo Patterson described a new method of processing a diffraction pattern while avoiding the phase problem. The function he described became known as the Patterson function. The Patterson function contains vectorial information between atoms in a molecule. The rotation function involves a Patterson search that searches for solutions that will give high overlap between the data and the model. The Patterson states that the vector describing the data (P( u)) is (P(u)) = Lh F/ exp [-i1tihu] ( eqn. 4) where Fh 2 is the structure factor amplitudes squared :Eh is the summation of all reflections on the order of h. h is order of diffraction. 3 1  
u represents individual vectors. The rotation function is calculated by the equation: R(c) = J uLr Pm (Cu) Px (u) dV (eqn. 5) where (R(c)) is the rotation function ( c) is the rotation matrix. (Pm) is the Patterson of the search model. (Px) is the Patterson of the experimental data. U is the search radius. V is the volume of the unit cell. The integration sums all · the products of the Patterson of the model multiplied by the rotation Matrix (C) and the Patterson of the data over all values of the vector u that are less than the radius. The radius is usually defined as the radius of the search molecule. The self rotation function rotates the data on itself. The second rotation function is the cross rotation function. If the search model and the experimental are highly homologous, then these vectors should almost be identical. As shown in the equation for the rotation function, it is necessary to calculate the rotation matrix (C) (Rossman and Blow 1 962). The set of angles, which traditionally have been used to define the rotation · of one molecule to the next are the eulerian angles (shown in Figure 2.5). These angles are used to simplify the amount of rotation. The axis with highest symmetry is set to z. The first rotation, 0 1 , rotates around the z axis. The second rotation, 02, rotates around the y axis. The last rotation, 03 , is a second rotation around the z axis. This type of rotation is equivalent to rotating all axes. The rotation matrix is defined by the eulerian angles and 32 
Figure 2.5. Eulerian angles a, J3, y used for the rotation search. 33 
Table 2.1 Rotation matrix composed representing eulerian angles between the Patterson of the data and the Patterson of the search model (Rossman and Blow 1962). 
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,in 6t ein Bi - (l0$ 82 "in 8a is shown in Table 2. 1 .  The plot of the rotation function in the eulerian angles, shown in Figure 2.6, show peaks that represents a solution. The highest signal to noise peaks from the rotation function are used for the translation function. These will also have the best correlation coefficient, which is defined by the equation: Correlation Coefficient = Jv (Px- Pm) (Gx-Gm) dV (Jv (Px2 -Pm2) dV fv (Gx2-Gm2) dV) 112 (eqn 6) where Px is the Patterson of the data Pm is the Patterson of the search model Gx is the interference function associated with the data Gm is the interference function associated with the search model V is the volume of the unit cell G represents the interfemce function, which is related to the volume of the sphere around the search molecule and the radius of the search molecule (Rossman and Blow 1 962). After the rotation function is calculated, the total correlation of the search model to experimental data is still fairly low as the translational position has yet to be determined. The translational coordinates are calculated by the translation function. 34 
Figure 2.6. The rotation and translation functions for the JtoR68S structure. (a) A peak representing a solution from the rotation function and (b) a peak representing a solution from the translation function. Maps were contoured at I cr. 
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However, before one attempts to perform the translation function, one must first ascertain the number of expected molecules in the unit cell. 
Deriving Matthews Volume The Matthews coefficient determines the solvent content of the asymmetric unit. The average crystal has a solvent content of approximately 30-70%. A typical crystal that diffracts to 2A resolution is expected to contain about 40-50% solvent. By this point we know the space group of the crystal, which tells us how many asymmetric units we have in the unit cell. With this knowledge we then can ascertain how much of the unit cell is composed of protein molecules. To do this we use the relationship: Solvent content = volume of unit cell (A) (no. of asymmetric units in the unit cell) x (molecular weight) ( eqn 7) After calculation of the number of molecules in the asymmetric unit, we then perform the translation function for each molecule in the asymmetric unit using the solution from the rotation function as our search model (Blow 2002). 
Translation Function A translation function is derived for at least the top50 rotation function solutions. The translation function is defined by the equation: T(x) = LH mH [Px]2 [Pm]2 (eqn 8) Where (Px) is the Patterson of the data (Pm) is the Patterson of the model LH mH, sets the limit of the translation to the unit cell defined by reflection H 36 
Two sets of vectors are calculated in the translation function. The first is the crystallographic set of vectors, which is defined by crystal symmetry. An example would be the set of vectors between a molecule at the origin and its 41 -related symmetry mates. The second set of vectors are the non-crystallographic vectors, which are calculated between sub-units in the asymmetric unit. Initially crystallogranophic vectors are used for ascertaining the translation function solutions. Then the top solution is fixed at the origin and the non-crystallographic vectors that relate this solution to the other molecules in the asymmetric unit are used to find their relative translational position. After each translation solution is found the correlation coefficient will increase if the solutions are correct. The correlation coefficients are calculated as follows: ( eqn 9) where Fo is the observed structure factor amplitudes from the data Fe is the calculated structure factor amplitudes from the search model After the translation function is performed the correlation �etween the solutions and the data should be increased. After the solution have been found, AmoRe will check the solution by performing a round of rigid body refinement with the program Fitting. Rigid­body refinement is considered to be another checking procedure, to prove the correctness of the solutions. In rigid-body refineme�t the molecule is treated as one rigid body where each atom does not move independent of the other atoms in the molecule. Performing rigid body refinement allows for optimizing the positions of each solution to match the 37 
data. If the solutions are correct, the refinement should result in an increase of the correlation coefficient and a decrease of the R-factor, which is calculated by: (eqn 10) The R factor is a measure the agreement between the calculated model and the observed data. A lower R-factor implicates a model reflective of the observed data. If the solutions are determined to be good solutions, then the phases associated with search model can be applied to the data allowing us to solve the wave equation and the structure (Blow 2002). 
Refinement Of The Structures After the structure of the protein is determined, we must now analyze and refine the model to better fit the data. To do this we create an electron density map defined by the following equation: p(xyz) = ( IN) LhLkLI (2Fo-Fc) e (cpc) e ·21tI(hx+ky+lz) (eqn 1 1 ) where p(xyz) represents the electron density V is the volume of the unit cell Fo is the structure factors related to the data Fe is the structure factors related to the model. q>c represents the phase hx+ky+lz represents the position in reciprocal and real space A 2Fo-Fc map is normally used in viewing electron density, because it gives weight to the structure factors of the data (2Fo), thus reducing biasing which may can be introduced 38  
from the model. To properly address the bias implemented into the electron density map by the model, several simulated annealing (SA) omit maps are generated. The SA omit maps omit groups of five residues from the model before performing simulated annealing and calculating a 2Fo-Fc electron density map. In doing this, the bias from the model is eliminated. After the SA omit maps have been calculated, one must manipulate the model to fit the electron density. This is otherwise known as modeling. After the modeling is performed one must then subject the structure to a round of refinement, which restrains the structure to standardized bond angles and lengths as well as permitting better fitting of the model to the data. In refinement, the amplitudes of the model are calculated by inverse Fourier synthesis and compared to the amplitudes of the data. In calculating the structure factor amplitudes of the data, errors can be produced from weak reflections. These reflections, through counting errors, may sometimes have negative intensities. These negative intensities cannot be used or omitted for refinement calculations. To address this problem, a statistical method, developed by French and Wilson (French and Wilson 1 978), based on Bayesian statistics has been implemented in the program TRUNCATE. Baye's theorem states that the confidence of a parameter, P, can be modified by an experimental measurement, X. Thus the desription of parameter P can be expected by comparison to the observation (French and Wilson 1 978). The effectiveness of the modeling is gauged by the R-factor (shown in equation 1 1  ). However, as refinement progresses, the data is biased towards the model. This can be seen in the equation from REFMAC, a program for minimization. M =rhkl Wr (Fo-GFc)2 + LbkIWp (�o-�c)2 + Lbkl Wct (dt-dc)2+rhk1Wb(bo-bmin)2 + Lhkl WvV (eqn 12) 
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Where Wris the amplitude weighting coefficient (F0-GFc) is the Difference in the structure factor amplitudes of the data and the model with the model scaling factor G WP is the phase weighting coefficient ( �o-�c) is the difference in the phase of the final solution from molecular replacement and the phase of the final model. W d is the restraints weighting coefficient dt is the target interatomic distances de is the calculated interatomic distances W b is the non-bonded weighting coefficients (bo-bnun) describes the differences in non-bonding interactions V is the determinant of the product-moment matrix of a planar group of atoms W v is the weighting coefficients for planarity restraints Notice in this equation that (�0-�c)2 is represent the phase of the final solution from molecular replacement minus the phase calculated from the model. Since both are phase from the models, this biases the electron density, which represents the data in real space, towards the model. To alleviate this bias, another value, R-free, is also calculated to better ascertain the agreement between the model and the data. To calculate an R-free value, data is withheld from the refinement calculation, thus is never biased by the refinement process. Usually five to ten percent of the data is used for calculating the R­free, and the R-free is calculated in a similar fashion as the R-value, which is shown in equation 7 (Murshudov, Yagin et al. 1 996) . 
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Conjugate Gradient Refinement Refinement of a model structure manipulates the model to better fit the data. This process involves the movement of four parameters involved with the structure: x, y, z, and B. X, y, z, represent the coordinates required to describe a point in three dimensions, and the B-factor represents the amount of thermal motion associated with each atom. B factor are calculated by the equation: Bj = 81? {u2j } (eqn 1 3) where { u2j }  represents the displacement of an atom from its resting position Bj represent the calculated B-factors in A 2 · This can now be accounted for in our structure factor calculation, where equation 4 becomes: F(h,k,l) = nLj-tfj e 21tl (hx+ky+lz) e (-Bj sin2 8/A.2) (eqn 14) 
Maximum-Likelihood Method To refine the JtoD29A structure and the JtoR68S structures we used two programs: CNS and REFMAC (Murshudov, Yagin et al. 1 996). However, both programs implemented the same method of refinement: the Maximum Likelihood Method. The idea behind of maximum likelihood refinement is simple: the best model is most consistent with the observations. The consistency is measured statistically, measuring the probability that an observation should have been made. The probability is calculated by taking the joint probability of all reflection of the calculated and observed structure factor amplitudes. This is shown in the equation: P(max likelihood) = TT P[(Fobs);(Fcalc)] (eqn 1 5) 41  
where fl P is the joint probability that data is similar to the model Fobs is the structure factor amplitudes of the data Fcalc is the structure factor amplitudes of the model When we perform modeling on the structure to better fit the electron density, which represent the data, the likelihood goes up, indicating that the model is better. The probabilities have to include the effects of all sources of error, including not just measurement errors · implicit in the data but also errors in the model itself. But as modeling progresses and the structure improves, the model errors decrease, which means the probabilities start to increase. Increasing the probabilities also increases the likelihood (Murshudov, Yagin et al. 1 996). A diagram outlining the cycle of refinement and model building can be found in Figure 2. 7. 
Simulated Annealing Simulated annealing, which is a molecular dynamic method, is another method of refining a structure. A simulated annealing experiment computationally heats the protein to a high temperature (3500K) and then slowly cools the protein back down to ambient temperature. When a protein folds it will fall into a local energy minima, which is presumably the thermodynamically favorable state. However, a global minima may exist that is lower than local minima, but the protein is unable to proceed to it because of energy barriers surrounding the minima in which the protein sits. Increasing the temperature of the protein will provide the energy for the protein to rise above all energy barriers. However, restraints must be applied to the calculation, which will prohibit the breakdown of the protein. These restraints include bond lengths and bond angles. The 
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Initial refinement of model from molecular replacement in CNS 
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View model and 2Fo-Fc electron density map in 0 
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Figure 2.7. The refinement protocol used to refine both the JtoD29A and the JtoR68S structures. 
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restraints are applied in Hooke's Law, which states that the force exerted by a spring is equal to a constant (k, the Hooke's constant) multiplied by the change in position of the spnng. This is shown in the equation: F = k (x1 -xo) (eqn 1 6 ) Where F is the force K is the Hooke's constant (x1 -x0) is the difference in initial position and the final position of the springThe Hooke's constant provides a limit to the amount of stretching .of the spring. In the case of a protein, the spring is analogous to the bond lengths and bond angles. Thus, Hooke's law is applied to the simulated annealing calculation to prohibit the breakdown of the protein during the heating stage of the calculation. As the protein is cooled it will fall into the lowest possible energy minima. However, this may produce a structure with distorted geometry. After the initial structure was solved we then performed positional refinement and modeling based on calculated electron density . 
Hydrophobic Surface Area Calculation To calculate the hydrophobic surface area of the JtoD29A and JtoR68S we first used the program Naccess to calculate the solvent accessible surface area (Hubbard and Thorton 1 993). Naccess calculates the atomic accessible area when a probe is rolled over the surface of the protein. The program uses the Lee & Richards method (Lee and 
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Richards 1971 ), whereby a probe of given radius is rolled around the surface of the molecule. The path of the probe is followed and traced out by its center. This resulting path is the accessible surface. Typically, the probe has a 1 .4A radius, which is the same radius as a water molecule, and thus creates a solvent accessible surface. · After NACCESS calculates the solvent accessible surface area, the results are shown for each atom in the structure. The solvent accessible surface area is divided into two sections, the polar and the apolar. Apolar residues include glycine, alanine, valine, leucine, isoleucine, proline, and methionine. However, polar residues may contribute apolar surface area to the structure. Examples may be exposure of C� and C1 by arginine residues. NACCESS reports the percent of each residue that contributes to the polar surface area and apolar surface area, as well as the total apolar and polar solvent accessible surface areas. 
Difference Distance Matrix Plots Difference distance matrix plots are useful tools in analyzing the difference in the Ca backbone of two similar structures. It is very useful when comparing two structures that are homologous or whose primary sequence differs by one residue, such as Jto, JtoD29A, and JtoR68S. The program works on a simple equation: 
Diff. = (Can(x) - Cam(x) ) - (Can(y) - Cam(y) ) ( eqn 1 7) where the distance in A of a Ca between residue n and m of protein y is subtracted from the distance in A of a Ca between residue n and m of protein x. The calculation is done for all possible distance, where n and m can be any possible residue in the protein. In doing so all possible distances between Cas in a structure are calculated and compared to the second structure. The results are displayed in a matrix plot for ease of analysis. If 
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slight changes occur between two structures, then they can be observed in the matrix plot. The sensitivity range in difference density plot can set to observe differences as small as 1.5A. All difference density matrix plots were calculated using DDMP from Yale University. 
Electrostatic Surface Area Calculations The protein surface is responsible for the interaction of the protein with the aqueous environment around it as well as other proteins and ligands. These interactions can be driven by the exposure of charged surfaces. To observe if any differences in charge occurred on the surface of the protein, we calculated electrostatic potential surfaces for Jto, JtoD29A, and JtoR68S using the program DelPhi (Rocchia, Alexov et al. 2001 ) .  DelPhi will calculate the electrostatic potential surface utilizing the Poissman­Boltzmann equation: 
v7 · i (r) v7 ¢(r) = Pmaa-o (r) + E Qinf exp-qit/J(r)/kT i ---------------------------" eqn 18) where pmacro is the overall charge density plus the sum of the charged density due to dissolved charged ions ni is the number of ions of type i in solution qi is the charge on the ion � is the electrostatic potential in that region of space k is Boltzmann's constant T is the temperature. 46 
The equation results in the calculation of reverse finite difference in the electrostatic potential on the surface of the protein. The Green theroem is appled to the electrostaic potential, which results in the formation of grid of electrostatic potentials. This grid may be used to map the surface electrostatic potential across the surface of the protein (Watson and W arwicker 1982). A dielectric is a medium that is a sufficient supporter of an electrostatic field. The lower the dielectric, the greater the electrostic potential, while the higher the-dielectric reults in a lower dielectric potential. This is shown in the case of water, which has a high dielectric, where ions have a greater chance of shielding because of the amount of water molecules present. However, in the interieor of a protein, ions have a lesser chance of shielding, which results from the low dielectric of the hydrophobic interior. Thus, they have a strong electrostic potential. DelPhi allows the user to set the dielectric of the solvent and the solute (macromolecule). The dielectric of the solvent is set to 80, which is the dielectric of water. The dielectric of the solute is set to 2, which is the approximate dielectric of the interior of a protein. After calculation of the electrostatic potential surface, the surface can be displayed in a program like Insight. 
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Chapter 3: The High Resolution Structures of JtoD29A and JtoR68S at pH 5.0 
Crystallization Of JtoD29A And JtoR68S The JtoD29A protein was crystallized m the space group P4122, where P represents the primitive Bravais lattaice, 41 represents the tetragonal crystal system with a 4-screw axis of symmetry . parallel to the c axis, and the 22 represents the 2-fold symmetry axes parallel to and b. JtoR68S crystallized in both the P4122 and the P212 12 1 space groups. The P212 12 1 space group has a 2-fold symmetry along all three axis which defines the orthorhombic crystal systems (Ladd and Palmer 1 985). Crystals were grown by vapor diffusion at 25°C. JtoD29A was crystallized in a mother liquor containing 0.8 M ammonium sulfate, 0. 1 M sodium acetate pH 5.0, and 0. 1 M cadmium chloride. A 10  mg/ml solution of JtoD29A protein was equilibrated with the mother liquor in a 1 :  1 ratio. The crystals were improved by subjecting the above condition to detergent and additive screens purchased from Hampton Research, USA (Garvito 1986). The best crystals were obtained when the detergent n-Decyl-B-D­maltoside was added to the hanging drop at its CMC. JtoR68S crystals were similarly crystallized by using a mother liquor of 0.8 M ammonium sulfate, 0. 1 M sodium acetate pH 5 .0, and 40 mM cadmium chloride. A 14 mg/ml solution of JtoR68S protein was equilibrated with the mother liquor in a 1 :  1 ratio. Both JtoD29A and JtoR68S crystals grew in the space group P4122 with the unit cell dimensions shown in Table 3. 1 .  The physical dimensions of the JtoD29A and JtoR68S crystals were 0.5x 0. l x  0. 1 mm3 • 48 
Table 3.1. Statistics and unit cell dimensions of the JtoD29A and JtoR68S crystal structures 
JtoD29A JtoR68S 
Number of molecules per asymmetric unit 2 2 
Rvm 6.5% 6.6% 
Resolution 14.74 - 1 .60 1 5.00 - 1 .90 
Completion 97.3% 95% 
Rrree 29.3% 23.3% 
Non-hydrogen protein atoms/asymmetric unit 1 766 1 820 
Metal ions/ asymmetric unit 4 4 
Water molecules/ asymmetric unit 1 07 1 1 5 
Rms Deviations from Ideality 
Bond lengths (A) 0.0 1 7  0.009 
Bond angles ( deji) 1 .2 1 9  I . 1 90 
Space group P 4(1 )22 P 4(1 )22 
Unit cell dimensions 
a=73.57 A,b= a=72.2A, b=72.2A, 
73.57 A, c=92.29A c=94.3A 
cx=J3=y=90°, 90°, cx=J3=y=90°, 90°, 
90° 90° 
Data Collection And Processing Cryoprotection of _both JtoD29A and JtoR68S crystals was achieved by soaking crystals in respective mother liquors containing 10-15% glycerol. Diffraction data for all of the JtoR68S were collected at a temperature of -160° C at a wavelength of 1.5418 A using a Rigaku RU-H3R rotating anode X-ray generator with osmic focusing mirrors using a R-axis Iv++ image plate detector. The diffraction data set for JtoD29A were collected at the synchrotron source in Hamburg on DESY 9 source at the BW7A beamline by Dr. Remy Loris at the University of Brussels. Diffraction data were collected at -160°C and a wavelength of 0.97622A using a Mar image plate detector. All data were indexed, integrated, and scaled using the programs DENZO and SCALEP ACK (Otwinowski 1992). The scaled data from SCALEPACK were converted to the mtz format using the CCP4 program SCALEP ACK2MTZ and the structure factors were 49 
calculated using the program TRUNCATE that implements French and Wilson statistics (French and Wilson 1 978). In order to determine the space group, we created pseudo precession pictures using the CCP4 script HKL VIEW (Collaborative Computational Project 1 994). 
Structure Determination Of The JtoD29A And JtoR68S Mutants The JtoD29A and JtoR68S structures were solved using the molecular replacement method using the program AmoRe implemented in the crystallographic suite CCP4 (Collaborative Computational Project 1 994) by Dr. Vibha Gupta, a previous post­doctorial student in Dr. Dealwis' lab. In Amore ROTING calculates the rotation function, TRAINO calculates the translation function, and FITTING performs a rigid-body refinement of the structure. The model cell used for JtoD29A and JtoR68S was a=68.0 1 8  
A, b=58.388 A, c=59.037 A, a = J3 = y = 90° . We used data in the resolution range of 50-3.0A for conducting molecular replacement. The radius of integration used was 0.0 to 23.738 A. The three-dimensional X-ray structure of V,._6 Jto (PDB # I CDO), which differs at only one residue with respect to both JtoD29A (PDB # IPEW) and JtoR68S (PDB # 1PW3), was used as a search model. For JtoR68S, the correlation coefficients for the two molecules/asymmetric unit from the translation function were 25.0% and 24.7%, respectively. The largest noise peak had a correlation coefficient of 1 3%. After fixing molecule 1 to find the relative position of the second molecule using TRAINO, the correlation coefficient increased to 40.4%. Final fitting using the program FITTING further increased the correlation coefficient to 67.2%. For JtoD29A, the correlation 50 
coefficients for the two molecules/asymmetric unit from the translation function were 23.1 % and 20.2%, respectively. After fixing molecule l to find the relative position of the second molecule using TRAINO, the correlation coefficient increased to 39.4%. After final fitting the correlation coefficient increased to 65.6%. In order to fine tune the three orientation and three translational parameters the original solutions from MR were subjected to rigid-body refinement using CNS (Bruenger, Adams et al. 1998). This was followed by a round of simulated annealing and positional refinement using CNS. 
Refinement Of JtoD29A And JtoR68S After several rounds of positional refinement using CNS (Bruenger, Adams et al . 1998) interspersed with model building using the program O (Jones, Zou et al. 1991 ), we started to use REFMAC (Murshudov, Yagin et al. 1996). Though REFMAC is another refinement method based on the maximum likelihood method of refinement, it differs from CNS in sev�ral ways. REFMAC permits manual manipulation of the weighting schemes more readily than CNS_. When using REFMAC we applied a high weight to the data to ensure- that the model refined towards the experimental data. We also found several side-chains that had multiple conformations, and REFMAC permitted the refinement of multiple conformations of side-chains with ease. Finally both structures were subjected to B-factor refinement using REFMAC. As REFMAC was unable to refine occupancy of the alternate conformations, we conducted B-factor refinement for comparing the relative occupancies by analogy to the B-factors. 
5 1  
The final model of JtoD29A refined to a crystallographic R-free value of 29.3% at 1 .6 A resolution. The rms deviations from ideality in bond angles and bond lengths were 1.219 ° and 0.017A, respectively. The final model of JtoR68S refined to a crystallographic R-free value of 23.34% at 1.9 A resolution. The rms deviations from ideality in bond angles and bond lengths were 1.19° and 0.009 A, respectively. Both proteins crystallized in the space group P4 122 with two molecules, A and B, in the asymmetric unit. The two molecules of JtoR68S were structurally identical. However, in the JtoD29A crystal, the electron density of the B molecule �ontained regions of disorder and overall possessed poorer density than molecule A possibly contributing to the high R-free value. The JtoD29A structure was also refined in a low symmetry space groups, P4 1 and P222 1, in order to eliminate error in space group assignment. In neither case was the final R-free value significantly lower with respect to the model refined in the P4 122 space group. We ascribe the high R-free of the JtoD29A structure to the disorder observed in molecule B, which has a different crystal packing environment to that of molecule A. Both JtoD29A and JtoR68S were crystallized in the presence of cadmium chloride and the resulting structures contained four bound Cd2+ ions per asymmetric unit. In addition, the refined structure of JtoD29A contained 107 water molecules while that of JtoR68S contained 115 water molecules. In JtoD29A, the loop containing residues 39-42 is disordered. At 1.6A resolution we were able to observe 7 alternate side-chain conformations for residues Met3, Ser55, Arg68b, Leu78, Lys 79, Va196 and Arg l03 in the JtoD29A structure. 52 
The average main-chain B-factor for the JtoR68S molecule is 15.6 A2 and for the side-chains, 15.4 A2 • As anticipated, due to the inherent disorder observed in the JtoD29A structure the corresponding B-factor values of 21.9 A2 and 21.3 A2 were higher than those of JtoR68S. This is also consistent with the fact that the JtoD29A structure has a high Rfree value of 29.3% where as JtoR68S has an Rfree value of. 23.3%. The rms difference between molecules A and B of both the JtoD29A and JtoR68S crystals was 0.438A and 0.516 A, respectively suggesting almost complete identity. Therefore from this point onwards we will only describe comparisons and structural analyses conducted using molecule A of both protein. 
2Fo-Fc Omit Maps Of The JtoD29A And JtoR68S Mutants The 2F o-F c difference omit maps derived after several rounds of rigid-body refinement followed by a few rounds of positional refinement unambiguously defined the electron density of the mutated residues in both JtoD29A and JtoR68S (Figures 3. l a  and l b). The omit map of JtoD29A was produced by computationally replacing Asp29 with Gly. Figure 3. l a  shows clearly electron density for the Asp to Ala substitution at position 29 in JtoD29A, while figure 3 . lb shows electron density for the Arg to Ser substitution in JtoR68S. 
Comparison of the main-chain conformations of Jto, JtoD29A, JtoR68S, and Wil To determine whether significant main-chain conformational changes had arisen due to substitution of residues 29 and 68, the structures of JtoD29A and JtoR68S were superimposed with the wild-type structure of Jto (Figure 3.2) and further compared to 53 
Figure 3.1. 2Fo-Fc omit maps generated at the site of the mutation for (A) JtoD29A 
model shown at the mutation site, D29A, and (B) the JtoR68S model shown at the 
mutation site, R68S. The contour level was set at 1 cr and the Jto sequence was modeled 
in order to show that the electron density for the mutation was unambiguous. The figure 
was prepared in O (Jones, Zou et al. 1 99 1 ). 
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Figure 3.2. Main-chain Ca superposition of Jto (gray), JtoD29A (green), JtoR68S (red), and Wil (Blue) using the program LSQMAN implemented in O (Jones, Zou et al. 1991 ). Inset table shows the root mean squared (rms) differences between all four structures. Figure was prepared using the program Insight II (Biosym Technologies, San Diego). 
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another V i6 LC structure Wil. All four molecules are virtually identical except within the immediate vicinity of the Asp29Ala and Arg68Ser mutations. Ca. rms differences between the three models are shown in the inlay of Figure 3.2. The rms difference between Jto and JtoD29A is 1.368 A, while it is 0.669 A compared to JtoR68S. The rms difference between JtoD28A and JtoR68S is 1.157 A. The main-chain rms differences between each of the Jto variants and the highly amyloidogenic V1..6 Wil protein, were also determined (Figure 3.2) (Pokkuluri, Solomon et al. 1999). Not surprisingly, there is a high structural homology between the four V ,i,6 LC structures as shown by low the Ca 
rms differences (Figure 3.2). 
Side-Chain Conformational Analysis Although the main-chain conformations of the four V1..6 LC proteins are almost identical, there are several side-chain conformational differences that result from the mutations. With reference to Jto, the side-chain residues most affected by the mutation in JtoR68S or JtoD29A are: His8, Ser36, Arg54, Arg61, Ser76, Leu78, Arg79, Glu81 and Gly108. Significant side:--chain conformational differences are observed at the site of mutation (Figure 3.3). Both the D29A and the R68S mutations destroy the stabilizing ionic interaction between Asp29 and Arg68 seen in Jto. This in turn propagates reorganization of some of the neighboring side-chains. Examination of the structure surrounding the Arg68Ser substitution indicates that the side-chains of Asp29, Asn3 l and Ser68b undergo conformational changes. For example, in JtoR68S the loss of an ionic interaction is being compensated by the formation of a new hydrogen bond between the 56 
Figure 3.3. Superposition of Jto (white), JtoD29A (green), and JtoR68S (red) around the sites of mutations, residues 29 and 68. Side-chain conformational changes are observed at N29, D29, S68b and R68. Notice in JtoR68S (red) that N29 moves to form a new hydrogen bond with D29. The figure was prepared using the program Insight II (Biosym Technologies, San Diego). 
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carboxyl oxygen of Asp29 and the side-chain nitrogen atom of Asn31 (Figure 3 .3). The hydroxyl group of the substituted Ser68 is solvent exposed and not involved in hydrogen bonding interactions with other parts of the protein. In the absence of the hydrogen bond donor Asp29, the guanadinium side-chain of Arg68 in JtoD29A, undergoes a conformational rearrangement and the guanadinium group points towards solvent as compared to Jto due to the disruption of the ionic interaction (Figure 3.3). In the vicinity of the mutation in JtoD29A, we do not observe the same side-chain conformational changes for Asn29 and Se_r68b as observed for JtoR68S (Figure 3.3). Instead they adopt a similar conformation to the corresponding residues in the Jto structure. Slight differences in side-chain conformation were found in several regions of the JtoD29A and JtoR68S structures. Interestingly, we found that most of these differences were localized to the surface of the molecules. We expected that these conformational differences would affect the solvent exposed surface area of the protein. To test this we next examined both the hydrophobic surface area and the electrostatic surface potential. 
Comparison Of Hydrophobic Surface Areas As JtoD29A and JtoR68S crystallize in the same space group with identical unit cell dimensions, which implies similar crystal packing effects, we are able to do detailed comparisons such as hydrophobic surface accessible area and electrostatic potential surface areas with confidence. A comparison of the hydrophobic surface between the JtoR68S versus JtoD29A may offer some clues to explain the differing kinetics of fibril formation observed for these two mutants. We used the software package ACCESS (Hubbard and Thorton 1993) to calculate the solvent accessibilities for both the 
58 
JtoR68Sand JtoD29A structures. If Gly, Ala, Val, Ile, Leu, Met and Phe are used as the hydrophobic residues, there is a 42.5 A2 increase in solvent accessibility, indicating that a larger hydrophobic surface area is exposed in JtoR68S as compared to the JtoD29A structure. A less cons_ervative approach to looking at non-polar surfaces as compared to using strict hydrophobic residues alone will involve the inclusion of apolar atoms from all side-chains. Using this method we have generated an apolar surface area of JtoR68S, which includes the apolar atoms possessing greater accessible surface area as compared to JtoD29A (see Figure 3.4). Residues 5, 7, 14, 15, 18, 19, 20, 27A, 29, 32, 61, 63, 79 and 94 have higher apolar surface accessibilities in JtoR68S as compared to JtoD29A (Figure 3.4). It is important to note that 64% of these residues belong to the first N-terminal �­hairpin turn spanning from residues 1-30. Moreover, this finding is consistent with the results obtained from a difference distance matrix plot (DDMP ) of JtoR68S versus JtoD29A shown in Figure 3.5. From Figure 3.5 it appears that the largest distance differences are found in two clusters. The first cluster is found between residues 4-28 and the second cluster is between residues 64-84. These same differences are also found in difference distance matrix plot between JtoD29A and Wil ( data not shown). As mentioned above the first cluster lies within the first 30 residue N-terminal �-hairpin loop that has a majority of the exposed apolar atoms (Figure 3.4 a and b). Interestingly a study involving a peptide derived from homologous residues 74-80 of cluster 2 from a V ,A LC protein LEN was shown to inhibit fibril formation (Davis, Raffen et al. 2000). It is 59 
Figure 3.4. A comparison of accessible apolar surface area between JtoD29 A and JtoR68S. (a) The surface area was calculated for JtoD29A, and JtoR68S using the program ACCESS (Hubbard and Thorton 1993). Shown in green are hydrophobic residues which are more exposed in the JtoR68S structure when compared to JtoD29A. Blue residues denote apolar regions of polar residues that contribute a greater amount of apolar surface in JtoR68S as compared to JtoD29A. The figure was prepared using the program Insight II (Biosym Technologies, San Diego). 60 
Figure 3.4 continuing from Figure 3 .4 (b) 1 80° rotation of the structure shown in Figure 3.4a. Notice that most of the hydrophobic surface is localized to the opposite side of the protein. Shown here is one residue, Pro40, which has an increase in exposure in JtoR68S. 6 1  
JtoD29A vs JtoR68S 
• 
::e{- · -
Figure 3.5. Difference Distance Matrix Plots \Vere calculated using the program DDMP (DDMP ). To calculate differences, the Ca. distance of JtoR68S was subtracted from the Ca. distance of JtoD29A. Plot of JtoD29A versu� JtoR68S shows the greatest differences in Ca. distances are found in two regions that 'Include residues 4-28 and 64-84. As the region consisting of residues 39-42 in JtoD29A_.was disordered in the structure we had to model this region based on the partially observed electron density and by using the Jto5 and Jto structures as guides prior to calculating the difference distance plot. 62 
worthwhile noting that cluster 2 consists of a strand that interacts with the above mentioned N-terminal �-hairpin loop containing the majority of the non-polar groups shown in Figure 3.4. Interestingly in another study, residues 29, 3 1 ,  6 1 ,  72 and 74 have been identified as risk factors (Stevens 2000). From these results we expect that both the first amino terminal �-hairpin and the �-strand comprising framework 4 may be susceptible spots for the formation of amyloid fibrils. 
Electrostatic Potential Surface Analysis There have been several studies that have shown correlation between surface charge of proteins and fibril formation (Gallo, Goni et al. 1 996) (Tjemberg, Hosia et al. 2002) (Pokkuluri, Gu et al. 2002). Since this study involves the structural characterization of two mutations that disrupts an ionic interaction due to the replacement of an acidic and basic residue by two neutral residues, we compared their respective electrostatic potential surfaces generated by the program Delphi (Rocchia, Alexov et al. 200 1 ). The Jto protein has an overall charge of -2, while the mutation (Asp29->Ala) in JtoD29A reduces the overall charge to - 1 ,  and the mutation (Arg68->Ser) in JtoR68S will increase the overall charge of the protein to -3 . The respective electrostatic potential surfaces are shown in Figure 3.6. The · effects of the mutations in JtoD29A and JtoR68S can be readily seen from the electrostatic potential surfaces. In Jto, the ionic interaction involving Arg68 represented by a blue positively charged area, and Asp29 represented by a red negatively charged area is readily observed in Figure 3 .6a. Upon mutation of Asp29 to an Ala in JtoD29A, a decrease is observed in the negative electrostatic potential surface (see Figure 3 .6b), while in JtoR68S, the Arg68 to a Ser mutation results in an 63 
Figure 3.6. Electrostatic potential surface for (A) Jto, (B) JtoD29A, (C) JtoR68S were calculated using the program Delphi (Rocchia, Alexov et al. 2001 ). The positively charged residues are shown in blue while the negatively charged residues are shown in red, and neutral charged residues are shown in white. The figure was prepared using the program Insight II (Biosym Technologies, San Diego). 64 
increase of the red negatively charged electrostatic potential surface (see Figure 3.6c). Interestingly, another group found that the mutation of a neutral glutamine residue at position 89 to an Asp increased the propensity for a K4 LC protein LEN, to form fibrils (Pokkuluri, Gu et al. 2002). The increase in negative charge contributed by the Asp89 was proposed to destabilize the structure of the LEN. Moreover, the study shows that a structurally related protein, Myelin Protein Zero (MPZ), contains Asp99 in an equivalent position that is involved in an ionic interaction with Arg38. The ionic interaction in MPZ contributes to stability and impairs fibril formation. This is closely related to what is observed in this study. In Jto, Asp29 and Arg68 forms an ionic interaction, which is analogous to the stable MPZ ionic interaction. In addition, the increase in JtoR68S's negative electrostatic potential surface may increase the propensity to form fibrils reminiscent to a second study (Tjemberg, Rosia et al. 2002), in which tetra peptides derived from Af3 demonstrated increased fibrilogenesis as charged residues were substituted for apolar ones. Figure 3.6 also shows that JtoD29A has a slight increase in positive surface area around Arg54. This difference in charged surface area is attributed to a guanadinium side-chain conformational change of Arg54, which is only found in JtoD29A. This further demonstrates the wide-ranging effects · on side-chain conformations resulting from a single amino acid mutation. 
Side-Chain Differences Observed In Wil Compared To The Jto Structures We have found that the unique ionic interaction in Jto, which is accredited with the increase in structural stability of the protein and prevention of amyloid fibrils, does not completely account for fibrillogenic properties. The main-chain of Wil superposes 65 
well with the Jto structures where the rms differences is only 0.8 A rms (Figure 3.2. ). As shown in Figure 3 .7, the side-chains of Tyr36, Tyr88, and Gln89 have the most dramatic conformational differences between the Jto structures and Wil. The origin of these conformational differences possibly results from the short hydrophobic Val96 in the Jto being substituted by a much longer polar G In residue in Wil. This substitution causes the side-chain of Gln89 to undergo a conformational change in Wil (Figure 3.7). None of the Jto-based structures could accommodate the Gln89 side-chain conformation adopted by Wil, as this would lead to a steric clash with the tyrosyl side-chain of residue 36 (Figure 3.7). For instance, the NDl side-chain atom of Gln89 of Wil almost occupies the exact position of the aromatic ring of Tyr36 in Jto, JtoD29A and JtoR68S (Figure 3 .7). Such structural perturbations are responsible for Tyr36 in Wil to adopt a different rotamer as compared to its position in the Jto-based structures (Figure 3 .7) . The side-chain conformational difference of Gln89 between Wil and the Jto-based structures is also responsible for displacing the tyrosyl ring of residue 88. Close examination of the four structures show that Tyr88 in Wil will sterically interfere with the side-chain positions of Gln89 in the Jto-based structures. Therefore Tyr9 l in the Jto-based structures have their tyrosyl side-chain displaced towards solvent alleviating steric clashes. Surface side-chain interactions have been shown to affect stability of protein (Davis, Raffen et al. 2000). The seventeen amino acid substitutions found in Wil as compared to the Jto-based proteins are responsible for the differing surface side-chain interactions, which may also contribute to Wil being the least thermodynamically stable V J6 LC protein out of the four. 66 
P40 Y91 V96 (Q96 in Wil) 
Figure 3. 7. Vast side-chain conformational differences are observed in Wil when compared to the Jto, JtoD29A and JtoR68S structures resulting from seventeen amino acid variations in the Wil amino acid sequence. At residue 96, the substitution of a glutamine for a valine, which is found in the Jto structures, propagates sterically induced side-chain conformational changes in Q89, Y91, and Y36. The figure was prepared using the program Insight II (Biosym Technologies, San Diego). 67 
Chapter 4: Determination of the structure of JtoR68S at pH 4.0 and pH 3.0 
It has been shown previously that fibril formation can be induced by mild incubations in denaturing conditions (Chiti, Mangione et al. 2001) (Chiti, Webster et al . 1999). These denaturants can be chaotropic agents, temperature, and low pH. However, total denaturation of the protein inhibits the formation of fibrils (Chiti, Webster et al. 1999). It appears that the protein must be partially unfolded by these denaturing agents to promote the formation of the fibrils (Chiti, Mangione et al. 2001) (Chiti, Webster et al. 1999) (Khurana, Gillespie et al . 2001) (Dobson and Evans 1988). It was also shown that decreasing the pH by small steps permits the trapping of intermediates, which are on the path to forming fibrils (Chiti, Mangione et al. 2001). These findings indicate that a protein can be induced into forming an intermediate. Thus, decreasing the pH of the mother liquor may allow for conformational changes of the protein, while crystal contacts will prevent total unfoding. Crystals may be soaked in low pH buffers in a time dependent manner in order to observe structural intermediates. 
JtoR68S Crystals Incubated At pH4.0 JtoR68S crystals were grown in 0.8 M ammonium sulfate, 0.1 M sodium acetate pH 5.0, which is the buffer of the initial JtoR68S crystals that are described in the preceding chapter. These crystals were subjected to X-ray diffraction experiments to ensure quality of crystals and isomorphism. The crystals belonged to an orthorhombic crystal system. Originally both tetragonal and orthorhombic crystals were obtained by Dr. Gupta. However, I was only able to crystallize the orthorhombic crystal forms. After the quality of the crystals were assessed to be good, an initial soaking experiment was 68 
performed to te�t the longevity of the crystal at pH 4.0. A single crystal was incubated in 0.8 M ammonium sulfate, 0. 1 M sodium acetate pH 4.0 until the crystal cracked and dissolved. This occurred after 45 minutes of soaking. After this, we performed a 5, 10, and 30 minute soak in the pH 4.0 buffer. After the soaks were completed crystals were incubated in a cryo-protectant containing 0.8 M ammonium sulfate, 0. 1 M sodium acetate pH 4 .0, 25% glycerol. X-ray diffraction data were collected on each crystal at -160°C. The unit cell dimensions of the JtoR68S crystal at pH 4.0 were a=70.544A, b=72.844A, c=96.284A, a.=�=y=90.0° . These cell dimensions · differ from the native crystal on two axes, the a and the c, which are 72.255A and 94.255A respectively (approximately 2% difference for each). The same unit cell dimensions were also found the ten minute soak. We attempted to process the data in P222 orthorhombic space group, and the space group was ultimately determined by utilizing pseudo precession pictures using the CCP4 script HKL VIEW. We found that the space group of both structures was P212121 . Both structures were solved by molecular replacement using the programs AMoRe and MOLREP (Yagin and Teplayakov 1997) using the CCP4 program suite. The RsymS of the five and ten minute soaks were 1 3 .9% and 9.9%, respectively. After one round of positional refinement in CNS the Rfree for the five minute �oak was 34.5%. Afterwards, a 2Fo-Fc map was calculated for analysis of the model. We examined the 2Fo-Fc map to locate regions that had undergone conformational changes. However, the electron density revealed no such changes. The model from molecular replacement for the ten minute soak was used for one round of positional refinement in CNS where the Rrree was 36.6%. Data collection and refinement statistics are shown 69 
Table 4.1. Statistics and unit cell dimensions of the JtoR68S pH 4.0 and 3 .0 crystal structures. 
pH 4.0 pH 3.0 
Number of molecules per asymmetric unit 2 2 
Rsvm 9.9% 2 1 .4% 
Resolution 35 - 2.5A 35 - 2.5A 
Completion 97.6% 98.9% 
Rfree 36.6% 37 .7% 
Non-hydrogen protein atoms/asymmetric unit 1 820 1 820 
Space group P21212 1  P21212 1 
Unit cell dimensions 
a=70.54A,b= a=70.54A,b=72.84A, 
72.84A, c=96.28A c=96.28A 
a=�=y=90°, 90°, a=�=y=90°, 90°, 90° 90° table 4.1. A 2Fo-Fc map was generated to search for conformational changes, which were not found. A thirty minute soak, at pH 4.0, was performed next. However, the processing of the data set from this crystal was not possible. The crystal possessed a high mosaicity, which is a measure of disorder in the crystal, and the data could not be properly scaled or processed. This indicates that the crystal had become greatly disordered due to the length of the soak at pH 4.0. It was apparent that pH 4.0 would induce a change in the crystal, but we were not able to see any changes at short soak, while a longer soak resulted in an unsealable data set. At this point we decided to lower the pH even further and perform a short soak to try to promote conformational changes in the protein while maintaining the crystalline state. 70 
JtoR68S Crystals Incubated At pH 3. 0 JtoR68S crystals were subjected to an initial soak at pH 3.0 in 0.8 M ammonium sulfate, 0.1 M glycine pH 3.0 to determine longevity of the crystal at this pH. We found that the crystals would start to crack after fifteen minutes in the pH 3.0 buffer. We next subjected a single crystal to a five minute soak at pH 3.0. Afterwards, cryoprotection of the crystal was achieved by a short incubation in 0.8 M ammonium sulfate, 0.1 M glycine pH 3.0, 25% glycerol. An X-ray diffraction data set was collected on this crystal at -160°C. After the five minute soak the crystal was still isomorphous with cell dimensions of: a=71.399A, b=72.140A, c=96.053A, a=J3=y=90°. The structure was solved by molecular replacement using the CCP4 program MOLREP (V agin and Teplayakov 1997). The resulting Rsym for the data was 21.4%. After a single round of positional refinement in the CNS the Rfree value was 41.1 % (Table 4.1 ). A 2Fo-Fc map was generated to search for conformational differences. Several side-chains of residues were observed to have undergone conformational change. These residues were at positions His8, Ser9, Lys16, Thr46, Ser72, Asp82, Arg94, Asn95, Val96, Val97, and Phe98 . However, main-chain residues 94 to residue 98 were disordered (shown in Figure 4.1 ). Interestingly these residues comprise the bulk of CDR-3. However, the CDRs display a high degree of sequence variability (Chothia and Lesk 1987), and in the case of Jto, the stabilization of CORI by an ionic interaction between Asp29 and Arg68 prevents the formation of amyloid fibrils in vivo (Pokkuluri, Solomon et al . 1999). Since the CDRs are sites of high variability and in Jto the ionic interaction to CDR 1 appears to play a role in preventing fibril formation, the conformational change of a CDR may be an early 71 
Figure 4.1 .  2Fo-Fc electron density map shown with the model of the JtoR68S structure at CDR3 after one round of positional refinement in CNS. Notice that main-chain Ca. density is missing. 
72 
event in partial unfolding of a light chain. A simulated annealing omit map, omitting residues 90 to 95 was calculated for the molecule and used for extensive modeling of this region. A second round of positional refinement in CNS was performed resulting in a Rfree value of 37.7%. The decrease in the Rfree-value indicates that the modeling of this region was correct and that this region has a different main-chain conformation from the native model. The new conformation of the CDR is shown in Figure 4.2a in yellow compared to the native in red. The resulting model and 2Fo-Fc map calculated for the modeled region is shown in Figure 4.2b. 73 
Figure 4.2. Modeling of the CDR3 region. A. Modeling of CDR3 shown in red compared to initial starting structure shown in yellow. B. A 2Fo-Fc simulated annealing omit map calculated for CDR3 shown with the model, which was built using the omit map. 74 
Chapter 5: Conclusions and Future Directions 
The JtoD29A And JtoR68S Structures We have solved the structures of both the JtoD29A and JoR68S V">..6 light chain antibodies. Since both structures crystallized in the P4 122 space group we were able to make detailed analysis of the two structures. No significant main-chain conformational differences were observed. However, some side-chain conformational differences were observed resulting in a change in the solvent exposed surface areas. We found that the amyloidogenic JtoR68S has a greater exposure of hydrophobic surface area. Interestingly 67% of the residues contributing to this increase are localized to the first 30 residues of the protein, which comprises the first P-hairpin. Another cluster of residues is found in the FW 5, which has been previously suggested as a potential "hot spot" for amyloid fibril formation. Interestingly FW5 packs against the first P-hairpin. We suggest that the first P-hairpin is in fact a site of early unfolding, which results in the formation of the amyloid nuclei. This has been independently confirmed by inhibition of fibril formation, when using the 30 residue N-terminal peptide of LEN (Wall, personal communication). This type of assay was also performed for the V ,A LC LEN where a peptide composing residues from FW5, which was found to inhibit the formation of fibrils by LEN. Future work should concentrate on crystallization of the N-terminal peptide with the Light Chain molecule. We also found that the JtoR68S structure exposed more charged su_rface than the Jto and the JtoR68S. Exposure of charged surface has already been shown in V ,A LCs to promote the formation of fibrils. The increase in negative charge around the site of 75 
mutation in JtoR68S may play a role in this. To access the role of charge in fibril formation, we suggest performing fibril formation assays in higher concentrations of salt to counteract the effects of protein surface charge on the formation of amyloid fibrils. · The analysis of both the JtoD29A and the JtoR68S has indicated that global structural shifts do not occur between the amyloidogenic and the non-amyloidogenic protein. However, the difference in side-chain conformations results in the exposure of a different solvent accessible surface. In this study we have demonstrated how a native structure can provide clues about the amyloid phenomenon. Though the methods we have used are not new, they have not been used before for analyzing amyloidogenic proteins. 
Low pH soaks Of JtoR68S Crystals We were unable to find any conformational differences from the five and ten minute pH4 soaks. A thirty minute soak resulted in data that was unsealable. A short five minute soak at pH3 revealed conformational differences around CDR3. Further analysis indicates that the CDR3 is not involved in crystal packing. However, the stabilizing effects of the crystal lattice may prevent other parts of the protein from undergoing conformational changes. This presents a problem in the interpretation of the unfolding event, which leads to the nuclei. To alleviate this problem, we propose to do NMR experiments under similar buffering conditions. A second problem occurs at ascertaining the exact species that could be deemed the nuclei. Since, the structure of the nuclei is not known, we do not know if the structure(s) we see are relevant. To address 
76 
this problem we plan on using the native structure and the structures we determine at different pHs to perform molecular dynamic simulations. This work shows how small pH changes can perturb the native structure. Longer soaks and soaks in both lower and higher pH buffers will be attempted in the future. These structures will shed further light on the type of structural intermediates that might be present in the unfolding and/or fibrillogenic pathway. 
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Auto . dat for Den zo 
format raxis 4  1 0 0  
wavelength 1 . 5 4 1 8  
( monochromator filter ]  
cassette rotx 0 .  roty  0 .  
spot elliptical 0 . 8  0 . 8  0 
box 2 . 4  2 . 4 
background elliptical 0 . 9  0 . 9 0 
overlap spot 
( cros sfire y 0 . 2 5 9  x 0 . 2 7 2  xy 0 . 0 5 7 ] 
x beam 1 4 9 . 9 3 8  y beam 1 4 9 . 92 9  
( s kew 0 . 0 0 0 3 5 ] 
[ Y  scale 1 . 0 ] 
film rotation 1 8 0 . 0 0 0  
oscillation range 1 . 0  
oscillation start 2 
distance 1 0 0  
mosaicity 0 . 9 9 0 0  
title ' j to5 -tetragonal l 0min p H 4  soa k ' 
sector 1 to 8 1  
raw data file ' a2 4 0 # # # . osc ' 
film output file ' a2 4 0 # # # . x '  
box 2 . 4  2 . 4  0 
overlap spot 
[ error systematic 5 . 0  partiality 0 . 1 ]  
[ e rror posit ional 0 . 0 5 0 ]  
profile fitt ing radius 3 0 . 0  
peak search file ' peaks . file ' 
FIT x beam y beam cell crystal rotx roty rot z 
WRITE PREDICTIONS 
GO 
fix all 
START REFINEMENT 
[print no shifts no pro files ] 
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resolution limi ts 1 0 0  4 . 0  
fit crys tal rotx roty rot z 
go go go 
resolution l imi ts 1 0 0  3 . 0  
fit cel l  x beam y beam crossfire x y xy 
fit cassette rotx roty 
resolution l imi ts 1 0 0  2 . 5  
fit cell x beam y beam crossfire x y xy 
fit cassette rotx roty 
fit di stance yscale skew 
go go go go go 
print profiles 1 1 
calculate go 
Scalepack 
/usr/ local /scalepack<<EOF>scalepack_pH4_p41 2 2_y . log 
RESOLUTION 1 0 0 2 . 5  
NUMBER OF ZONES 1 0  
NUMBER O F  I TERATIONS 1 0  
EST IMATED ERROR 0 . 0 8 0  0 . 1 0 0  0 . 1 00  0 . 1 0 0  0 . 1 0 0 . 0 1 0  0 . 0 8 0 . 0 4 0 . 0 4 0 . 0 4 
ERROR SCALE FACTOR 2 . 5 
SPACE GROUP P4 122  
OUT PUT FILE j to 5_pH4_p 4 1 2 2_y . sca 
reference film 1 
add partials 1 to 8 1  
format DENZO_yorkl 
[ scale restrain 0 . 1 ] 
POSTREFINE 10  
fit crystal a* 1 to 8 1  
fit crystal b* 1 to 8 1  
fit crystal c* 1 to 8 1  
fit crys tal beta* 1 to 
fit film rotx 1 to 8 1  
fit film roty 1 to 8 1  
fit crystal mosxx 1 to 
8 1  
8 1  
rej ection probability 1 . e-2 
write rej ection file 
@ rej ect 
[ vertical axis  O O 1 ]  
[ spindle axis O 1 O J  
Sector 1 t o  8 1  
FILE ' a2_4 0# # #_y . x '  
EOF 
S calepack2mt z 
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scalepac k2mt z hkl in j to5_ph4_p4 122 . sca hklout j to5_ph4_p4 1 2 2 . mt z  << 
eof>scalepack2mtz . log 
SYMM 91 
END 
eof 
#n example of extending data to p 4 1 2 2  
cad hkl inl j to5_ph4_p 4 1 2 2 . mtz hklout j to5_p4 1 2 2_ph 4_cad . mt z  
<<eof- cad > cad . log 
SYMMETRY 91 
LAB IN FILE 1 El= IMEAN E2=SIGIMEAN 
END 
eof-cad 
sortmt z HKL IN j to5_p4 12 2_ph4_cad . mtz HKLOUT 
j to5_p4 1 2 2_ph4_cad_sort . mt z  << EOF-sortmt z > sort . log 
# 
# Sort keys since default keys are H K  L 
# 
H K L 
EOF-sortmt z 
truncate hklin j to5_p4 12 2_ph4_cad_sort . mtz  hklout 
j to5 p 4 1 2 2  ph4 trunc . mtz <<EOF- trunc > truncate p4 1 2 2 . log 
t itle truncate-after scalepack o/p through cad -
wi lson 
resolut ion 58 2 . 5  
#rs cale 4 . 0  2 . 0  
nres idues 1 1 0  
labout F=FP S I GF=S IGFP 
EOF-trunc 
AmoRe Roting 
# s ort ing run : 
# #############  
# 
# mt z file contain s cell and symmetry . 
# 
amore hkl in j to5 p4 1 2 2  trunc . mtz  hklpck0 spmipch . hkl <<eo f>rot ing . log 
TI TLE ** spmi �pac king h k 1 F for crys tal * *  
SORTFUN RESOL 1 0 0 . 3 .  
LAB! FP=FP SIGFP=SIGFP 
eof  
# 
# tabl ing run : 
# ##############  
# 
# rotate and shi ft coo rdinates and produce table : 
# xyz out is  the rotated and shi fted coordinates . 
# 
amo re xyzinl . .  /auto/mono_renum . pdb xyzoutl searchrot . pdb TABLE l 
search . tab << eof 
TI TLE : Produce table for MODEL FRAGMENT 
VERBOSE 
TABFUN 
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CRYSTAL ORTH 1 CELL CRYS 7 2 . 2 5 
MODEL 1 BREPLACE 0 BADD 0 
7 2 . 2 5 
SAMPLE 1 RESO 3 SHANN 3 . 0  SCALE 4 . 0  
eof 
# 
# 
# 
# roting run : 
# # # # # # # # # # # # # #  
# 
94 . 2 5 
arnore TABLE l search . tab HKLPCKl search . hkl hklpck0 sprnipch . hkl clrnnl 
search . clrnn clrnn0 sprnipch . clrnn ROTING MI 4 0 0 0 0 0  ROTING MC 8 0 0 0 0 0  
MAPOUT arnore_cros s . rnap < <  eof  
ROTFUN 
VERB 
TITLE : Generate HKLPCKl from MODEL FRAGMENT 1 
GENE 1 RESO 2 0 . 0  3 . 0  CELL MODEL 68 . 0 1 8  5 8 . 3 8 8  5 9 . 0 37 
CLMN CRYSTAL ORTH 1 FLIM 0 . E0 1 . E8 SHARP 0 . 0  RESO 1 0 0 . 0  3 . 0  -
SPHERE 0 . 0  2 3 . 7 3 8  
CLMN MODEL 1 FLIM 0 . E0 1 . E8 RESO 1 0 0 . 0  3 . 0  SPHERE 0 . 0  2 3 . 7 38  
ROTA CROSS MODEL 1 BESLIMI 6 1 26  STEP 2 . 5  PKLIM 0 . 5  NPIC  100  
eof  
AmoRe Traing 
# 
arnore TABLE l search . tab HKLPCK0 sprnipch . hkl MAPOUT 
arnore_transj unk5 . rnap << eof > traing_p 4 1 2 2 . log 
TRAFUN CB NMOL 1 RESO 20 3 .  PKLIM 0 . 5 NPIC 1 0  
SYMM P4 1 2 2  
HKLM 2 1 9  2 1 9  2 1 9  2 5  
VERB 
T I TLE : j to5 
CRYSTAL ORTH 1 FLIM 0 . E0 1 . E8 SHARP 0 . 0  
SOLUTIONRC 1 1 8 . 5 9 47 . 4 3 2 91 . 3 5  0 . 0 0 0 0  0 . 0 0 00 0 . 0 0 0 0  1 0 . 9  
0 . 0  1 
SOLUT IONRC 1 7 1 . 4 1  1 32 . 5 7 1 1 1 . 3 5  0 . 0 0 0 0  0 . 0 0 0 0  0 . 0 0 0 0  1 0 . 9  
0 . 0  2 
SOLUT IONRC 1 8 5 . 67 7 8 . 0 0 1 8 3 . 8 8 0 . 0 0 0 0  0 . 0 0 0 0  0 . 0 0 0 0  7 . 6  
0 . 0  3 
SOLUT IONRC 1 4 . 3 3 1 02 . 0 0 3 . 8 8 0 . 0 0 0 0  0 . 0 0 0 0  0 . 0 0 0 0  7 . 6  
0 . 0  4 
SOLUTIONRC 1 2 8 . 57 4 7 . 9 5 2 9 9 . 0 0 0 . 0 0 0 0  0 . 0 0 0 0  0 . 0 0 0 0  7 . 2 
0 . 0  5 
SOLUTIONRC 1 6 1 . 4 3  1 32 . 0 5 1 1 9 .  0 0  0 . 0 0 0 0  0 . 0 0 0 0  0 . 0 0 0 0  7 . 2 
0 . 0  6 
SOLUT IONRC 1 6 9 . 63 7 3 . 8 9 2 4 9 . 3 6 0 . 0 0 0 0  0 . 0 0 0 0  0 . 0 0 0 0  6 . 5  
0 . 0  7 
SOLUTIONRC 1 2 0 . 3 7 1 0 6 . 1 1 6 9 . 3 6 0 . 0 0 0 0  0 . 0 0 0 0  0 . 0 0 0 0  6 . 5  
0 . 0  8 
SOLUTIONRC 1 4 5 . 4 4 31 . 8 6 2 0 0 . 3 8 0 . 0 0 0 0  0 . 0 0 0 0  0 . 0 0 0 0  6 . 1  
0 . 0  9 
SOLUTIONRC 1 4 4 . 5 6 1 4 8 . 1 4 2 0 . 3 8 0 . 0 0 0 0  0 . 0 0 0 0  0 . 0 0 0 0  6 . 1  
0 . 0  1 0  
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SOLUT IONRC 
0 . 0  1 1  
SOLUT IONRC 
0 . 0  1 2  
SOLUT IONRC 
0 . 0  1 3  
SOLUT IONRC 
0 . 0  1 4  
SOLUTIONRC 
0 . 0  1 5  
SOLUT IONRC 
0 . 0  1 6  
SOLUT IONRC 
0 . 0  1 7  
SOLUTIONRC 
0 . 0  1 8  
SOLUT IONRC 
0 . 0  1 9  
SOLUT IONRC 
0 . 0  2 0  
SOLUTIONRC 
0 . 0  2 1  
SOLUT IONRC 
0 . 0  2 2  
SOLUT IONRC 
0 . 0  2 3  
SOLUT IONRC 
0 . 0  2 4  
eof 
AmoRe Fiting 
# 
1 61 . 3 2 5 8 . 7 6  7 4 . 1 5 0 . 0 0 0 0  0 . 0 0 0 0  0 . 0 0 0 0  6 . 0  
1 2 8 . 6 8 1 2 1 . 2 4 2 5 4 . 1 5 0 . 0 0 0 0  0 . 0 0 0 0  0 . 0 0 0 0  6 . 0  
1 4 4 . 0 9 4 5 . 7 4 3 0 3 . 0 8 0 . 0 0 0 0  0 . 0 0 0 0  0 . 0 0 0 0  6 . 0  
1 4 5 . 9 1 1 34 . 2 6  1 2 3 . 0 8 0 . 0 0 0 0  0 . 0 0 0 0  0 . 0 0 0 0  6 . 0  
1 8 . 3 7 1 0 4 . 7 7 3 4 8 . 3 0 0 . 0 0 0 0  0 . 0 0 0 0  0 . 0 0 0 0  5 . 7  
1 8 1 . 6 3 7 5 . 2 3 1 6 8 . 3 0 0 . 0 0 0 0  0 . 0 0 0 0  0 . 0 0 0 0  5 . 7  
1 8 6 . 0 0 2 8 . 5 0 4 9 . 0 0 0 . 0 0 0 0  0 . 0 0 0 0  0 . 0 0 0 0  5 . 7 
1 4 . 0 0 1 5 1 . 5 0 22 9 . 0 0 0 . 0 0 0 0  0 . 0 0 0 0  0 . 0 0 0 0  5 . 7  
1 1 9 . 1 9 1 7 . 1 6 2 0 0 . 6 9 0 . 0 0 0 0  0 . 0 0 0 0  0 . 0 0 0 0  5 . 6  
1 7 0 . 8 1 1 62 . 8 4 2 0 . 6 9 0 . 0 0 0 0  0 . 0 0 0 0  0 . 0 0 0 0  5 . 6  
1 6 . 0 0 1 5 1 . 5 5 2 3 3 . 5 0 0 . 0 0 0 0  0 . 0 0 0 0  0 . 0 0 0 0  5 . 6  
1 8 4 . 0 0 2 8 . 4 5 5 3 . 5 0 0 . 0 0 0 0  0 . 0 0 0 0  0 . 0 0 0 0  5 . 6  
1 1 4 . 3 2 97 . 8 3 1 9 5 . 7 2 0 . 0 0 0 0  0 . 0 0 0 0  0 . 0 0 0 0  5 . 5  
1 7 5 . 6 8 82 . 1 7 1 5 . 72 0 . 0 0 0 0  0 . 0 0 0 0  0 . 0 0 0 0  5 . 5  
# fiting run : 
# #############  
# 
amore TABLEl search . tab HKL PCK0 spmipch . hkl <<eof > fiting_2mol . log 
FITFUN NMOL 2 RES O  2 0  3 . 0  ITER 10  CONV 1 . E-3  
TITLE * * *  j to5 
VERBOSE 
st ructure * * *  
CRYSTAL ORTH 1 FLIMI 0 . E0  1 . E8  
HKLM 2 1 9  2 1 9  2 1 9  2 5  
SHARP 0 . 0  
REF SOL AL BE GA X Y Z BF 
SOLUT IONTFl 1 18 . 5 9 4 7 . 4 3 2 9 1 . 35 0 . 8 7 2 8  0 . 3 5 3 6  0 . 4 2 4 0  0 . 0  
0 . 0  2 
SOLUT IONTF2 1 
5 1 . 2  2 
eof 
REFMAC 
# ! /bin/csh - f  
# 
71 . 4 1 1 3 2 . 5 7 1 1 1 . 35 0 . 9 0 3 8  0 . 3 7 81 0 . 8 3 1 5  4 0 . 4  
/ software /ccp4 - 4 . 2 . 1 /bin/ refmac5 HKL IN j to5_p4 1 2 2 . mtz  \ 
HKLOUT refmac_cyclel . mt z  \ 
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XYZ IN j toS_re fmac . pdb \ 
XYZOUT j toS_re fmac_out . pdb \ 
TLS IN re fmac tls . in \ 
TLSOUT re fmac_t ls_cycle2a . in \ 
<< eor>t . log 
# 
#####  Makecif parameters 
# Do not de fine links automati cal ly 
# Do not add hydrogens 
MAKE LINK N 
MAKE HYDR N 
# 
# 
# Input mt z labels 
# 
LAB IN FP=F SIGFP=SIGF FREE=FreeR_flag 
# 
# Output mt z labels  
# 
LABOUT FC=FC PH IC=PHIC FWT=2 FOFCWT PHWT=PH2 FOFCWT DELFWT=FOFCWT 
PHDELWT=PHFOFCWT 
# 
# Parameters of bu lk solvent based on constant value . They are 
de fault 
# 
SOLVENT VDWP 1 . 4  IONP 0 . 8 0 RSHR 0 . 8  
# 
# Weighting X-ray and geometry . Fairly tight re strants 
# 
WE IG MATR 0 . 1  
# 
# This  keywo rd says program that use 2 0  cyc les of  tls be fore 
# going to individual atomic rei fnement . Parameters of rigid 
# body groups are de fined in TLSIN tls . in 
REF! TLSC 15  
# 
# It  is  good idea to set all B value s to some value prior to 
# TLS refinement 
# - do it external ly so additional cycles use the refined B-values 
BFACtor SET to 3 0  
# 
# Use restrained ref inement after TLS . Al l re flections 
# will be used 
REFi nement TYPE RESTrained RESOlution 8 2 
# 
# Maximum likel ihood refinement 
# 
REFinement RES idual MLKF 
# 
# After TLS use istotropic  B values refinement . I n  very low 
resolution 
# it could be set to Overall B val ue refinement 
# 
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REFinement BREFinement ISOTropic 
# 
# Damp down shifts 
# 
DAMPing factor 0 . 5  0 . 5  
# -
# First and last cycles will print informat ion about out liers 
# In  all other cycles  only overa ll statistics will be monitorred 
# 
MONI MEDI 
# 
# Bul k solvent plus ani sotropic scal ing 
# 
SCAL TYPE BULK 
SCAL LSSC AN ISOT 
# 
# Number of individual atomic refinement 8 
# 
NCYC 1 0  
# 
END 
# 
eor 
CNS Minimi ze 
{ +  file : minimi ze . inp + }  
{ +  directory : xtal_refine + }  
{ +  description : Crystal lographic conj ugate gradient minimi zation 
refinement + }  
{ +  authors : Axel T .  Brunger,  and Paul D .  Adams + }  
{ +  copyright : Yale Univers ity + }  
{ +  reference : A . T .  Brunger , The Free R Value : a Novel Statistical  
Quantity for Assess ing the Accuracy of Crystal 
Structures ,  
Nature 3 5 5 ,  4 7 2 - 4 7 4  ( 1 9 92 )  + }  
{ +  reference : N . S .  Pannu and R . J .  Read, Improved structure re finement 
through maximum l ike l ihood, Acta Cryst . A5 2 ,  6 5 9 - 6 6 8  
( 1 9 9 6 )  + }  
{ +  reference : P . D .  Adams , N . S .  Pannu , R . J . Read and A . T .  Brunger ,  
Cross-val idated Max imum Likel ihood Enhances 
Crys tallographic 
Simulated Anneal ing Re finement , Proc . Natl . Acad . Sci . 
USA 
94 , 5 0 1 8 - 5 0 2 3  ( 1 9 97 ) + }  
{ - Guidelines for us ing this  file : 
- all str ings must be quoted by double-quote s 
- logical variables ( t rue / false ) are not quoted 
- do not remove any evaluate statements from the file 
- the se lect ions storel through store8 are available for general use 
- } 
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{ - begin block parameter de finition - }  de fine ( 
{ ======================= mole cu lar structure ------------------------- } 
{ *  molecular topology file * }  
{ ===> }  structure_infile= "alternate . mt f" ; 
{ *  parameter files * }  
{ ===> }  paramete r_infile l= " CNS_TOPPAR : prote in_rep . param" ; 
{ ===> }  parameter_infile_2= " CNS_TOPPAR : water_rep . param" ; 
{ ===> }  parameter_infile_3="cd_xplo r_par . txt " ;  
{ ===> } paramete r_infile_4 = " c is_peptide3 . param" ; 
{ ===> }  parameter_infile_S= " " ;  
{ *  coordinate file * }  
{ ===> } coordinate_infile= " alternate . pdb" ; 
{ ====================== crystal lographic data ======================== } 
{ *  space group * }  
{ *  use Internat ional Table convent ions with subscript s substi tuted 
by parenthe sis * }  
{ ===> }  sg= " P4 ( 1 ) 2 2 " ;  
{ *  unit cell parameters in Angs troms and degrees * }  
{ +  table : rows =l " cel l "  cols =6 " a "  "b"  " c "  "alpha " "beta" "gamma " + }  
{ ===> }  a=7 3 . 5 7 7 ;  
{ ===> }  b=7 3 . 5 7 7 ;  
{ ===> }  c= 92 . 2 98 ; 
{ ===> }  alpha= 90 ; 
{ ===> }  be ta= 90 ; 
{ ===> }  gamma= 90 ; 
{ *  anomalous f '  f ' ' library file * }  
{ *  I f  a file is not specified, no anomalous contribut ion will be 
included * }  
{ +  choice : " CNS XRAYLIB : anom cu . l ib" "CNS_XRAYLIB : anom_mo . l ib " " "  
user_file + }  
{ ===> }  anom_l ibrary= " " ;  
{ *  reflection files * }  
{ *  specify non-anomalous reflection files be fore anomalous reflection 
files . * }  
{ *  files mu st contain unique array name s otherwise errors will occur * }  
{ ===> }  reflection_infile_l = " j to2 . hkl " ;  
{ ===> }  re flection _infile _2 = '"' ; 
{ ===> }  reflection_ inf ile _ 3= '"' ; 
{ *  reciprocal space array conta ining observed ampl itudes : required * }  
{ ===> }  obs f= " fobs " ;  
{ *  reciprocal space array conta ining sigma values for amplitudes : 
required * }  
{ ===> }  obs_s igf=" sigma" ; 
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{ *  reciprocal space array contain ing test set for cross-val idat ion : 
required * }  
{ *  cross -val idation should always be used, with the pos sible except ion 
of a final round of re finement including all data * }  
{ *  cross -val idation is  always required for the maximum likelihood 
targets * }  
{ ===> } test_set= "te st " ; 
{ *  number for se lect ion of  test re flections : requi red for cross­
validation * }  
{ *  ie . reflections with the test set array equal to thi s number wi l l  be 
used for cros s-validation , all othe r reflect ions form the 
working set * }  
{ ===> } test flag=l ;  
{ *  reciprocal space array containing weighting scheme for obse rved 
ampli tudes : optional * }  
{ *  only used for the " res idua l "  and "vector" targets - thi s will 
default to a constant value of 1 if array is not present * }  
{ ===> } obs_w= '"' ; 
{ *  reciprocal space array containing observed intens ities : optional * }  
{ *  requi red for the "ml i "  target * }  
{ ===> } obs_i=" " ;  
{ *  reciprocal space array containing sigma value s for intensitie s :  
opt ional * }  
{ *  required for the "ml i "  target * }  
{ ===> } ob s_s igi= '"' ; 
{ *  reciprocal space arrays with experimental phase probability 
distribution : optional * }  
{ *  Hendrickson-Lattman coefficients A, B , C , D * }  
{ *  required for the "mlhl " target * }  
{ +  table : rows =l "HL coefficient s "  cols =4 "A" " B "  "C"  " D" + }  
{ ===> } obs_pa= " " ;  
{ ===> }  obs_pb= " " ;  
{ ===> }  obs_pc=" " ;  
{ ===> } obs_pd= '"' ; 
{ *  complex reciprocal space array containing experimental phas es : 
optional * }  
{ *  required for the "mixed" and "vector" targets * }  
{ ===> } obs_phase=" " ;  
{ *  reciprocal space array containing expe rimental figure s of merit : 
optional * }  
{ *  requi red for the "mixed" target * }  
{ ===> } ob s fom= " " ;  
{ *  resolution limits to be used in refinement * }  
{ *  the ful l resolution range of ob served data should be used in 
refinement . 
A bulk solvent correction shou ld be applied to allow the use of low 
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resolution terms . I f  no bulk solvent correction is applied, data 
must 
be truncated at a lower resolution l imit of between 8 and 6 
Angstrom . * }  
{ +  table : rows =l " resolution" cols=2 " lowest "  "highest" + }  
{ ===> }  low_res =2 0 ;  
{ ===> }  high_res=l . 8 ; 
{ *  apply rej ection criteria to amplitudes  or intensities * }  
{ +  choice : " amplitude " " intensity" + }  
{ ===> }  obs_type= " amplitude " ; 
{ *  Observed data cutoff criteria : applied to amplitudes or intensities 
* }  
{ *  reflections with magnitude (Obs ) / sigma < cutoff are rej ected . * }  
{ ===> }  sigma_cut=0 . 0 ; 
{ *  rms outlier cutoff : applied to amplitudes or intensities * }  
{ *  reflections with magnitude (Obs ) > cutoff* rms ( Obs ) will  be rej ected 
* }  
{ ===> }  obs_rms=l 0 0 0 0 ;  
{ ------------------- non-crystallographic symmetry ------------------- } 
{ *  NCS-restraints /constraints file * }  
{ *  see auxiliary/ncs . def * }  
{ ===> }  ncs_infile=" " ;  
{ ------------ initial B-factor and bulk solvent corrections ---------- }  
{ *  initial B-factor correction * }  
{ +  choice : "no"  " isotropic "  " anisotropic" " anisotropic_fixed_isotropic"  
+ }  
{ ===> }  bscale= " anisotropic " ;  
{ *  lower resolution limit for B-factor correction * }  
{ *  the correction can only be calculated using data truncated at a 
lower resolution l imit of between 8 and 6 A .  The correction will be 
applied to all reflections * }  
{ ===> }  low_res_bs cale= 6 . 0 ; 
{ *  bulk solvent correction * }  
{ *  a mas k  is  required around the molecule ( s ) . The region 
outside this mas k  is  the solvent region * }  
{ +  choice : t rue false + }  
{ ===> }  bulk_sol=true ; 
bulk  sol=true ; 
bulk mask=" " ;  
sol_k=- 9 9 9 9 . ;  
sol b=-9 9 9 9 . ;  
{ *  bulk solvent mas k  file * }  
{ *  mas k  will be read from O type mask  file i f  a name is given 
otherwise calculated from coordinates of selected atoms * }  
{ ===> }  bulk_mas k_infile= '"' ; 92 
{ *  solvent density level * }  
{ *  i f  negative , determined automatically 
i f  positive , fixed at value given * }  
{ ===> }  sol_k=-1 ;  
{ *  solvent B-factor * }  
{ *  i f  negative , determined automatically 
i f  positive , fixed at value given * }  
{ ===> } sol_b=-1 ; 
{ ========================== atom selection ===========·-=============== }  
{ *  select atoms t o  be included i n  refinement * }  
{ *  this should include all  conformations i f  multiple conformations are 
used * }  
{ ===> }  atom_select= ( known and not hydrogen ) ;  
{ *  select fixed atoms * }  
{ *  note : atoms at special positions are automatically fixed . So ,  
you don ' t  have to explicitly fix them here . * }  
{ ===> } atom_fixed= ( none ) ; 
{ *  select atoms to be harmoni cally  restrained during refinement * }  
{ ===> } atom_harm= ( none ) ; 
{ *  harmonic restraint constant - for harmoni cally restrained atoms * }  
{ ===> }  k_harmonic=l O ;  
{ *  select atoms i n  alternate conformation 1 * }  
{ ===> } conf_l = ( none ) ; 
{ *  select atoms in alternate conformation 2 * }  
{ ===> } conf_2= (none ) ; 
{ *  select atoms in alternate conformation 3 * }  
{ ===> } conf_3= (none ) ; 
{ *  select atoms in alternate conformation 4 * }  
{ ===> }  conf_4= ( none ) ; 
{ *  additional restraints  file * }  
{ *  eg . auxil iary/dna-rna_restraints . def  * }  
{ ===> }  restraints infile=" " ;  
{ --------------------- minimization parameters ----------------------- } 
{ *  number of minimi zation steps * }  
{ ===> } minimi ze_nstep=2 0 0 ; 
{ *  number of  cycles * }  
{ ===> } num_cycles =l ;  
{ *  refinement target * }  
{ +  list : ml f :  maximum likelihood target using amplitudes  
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mli :  maximum likelihood target us ing intens ities 
mlhl : maximum l i kelihood target us ing amplitudes 
and phase probability distribution 
residual : standard crystallographic res idual 
vector : vector res idual 
mixed : ( 1 -fom) *res idual + fom*vector 
e2e2 : correlation coefficient using normali zed E�2  
elel : correlation coefficient us ing normal ized E 
f2f2 : correlation coefficient using F�2 
fl fl : correlation coefficient us ing F + }  
{ +  choice : "mlf "  "ml i "  "mlhl " " res idua l "  " vector " "mixed" 
" e2e2 " "e lel " " f2 f2 "  " flfl " + }  
{ ===> }  reftarget="mlf " ; 
{ *  Wa weight for X-ray term * }  
{ *  this will be determined automatically i f  a negative value is given . 
Note : wa can be very di fferent depending on the target - i f  it  is 
not 
determined automatically make sure an appropriate value is 
used * }  
{ ===> }  wa=- 1 ;  
{ *  number o f  bins for refinement target * }  
{ *  this will be determined automatically i f  a negative value i s  given 
otherwise the specified number of bins will  be used * }  
{ ===> }  target_bins=- 1 ;  
{ *  memory allocation for FFT calculation * }  
{ *  this will be determined automatically i f  a negative value i s  given 
otherwise the specified number of words will be allocated * }  
{ ===> }  fft_memory=- 1 ; 
{ =========================== output files ---------------------------- } 
{ *  output coordinate file * }  
{ ===> }  coordinate_outfile= "minimizeS . pdb" ;  
{ *  format output coordinates for use in o * }  
{ *  i f  false then the default CNS output coordinate format will be used 
* }  
{ +  choice : true false + }  
{ ===> }  pdb_o_format=true;  
{ ====================================================================== 
===== } 
{ things below thi s  l ine do not normally need to be changed 
} 
{ ====================================================================== 
===== } 
) { - end block parameter definition - }  
checkversion 1 . 1  
evaluate ( $ log_level=quiet ) 
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structure @ &structure infile end 
coordinates @ & coordinate infile 
parameter 
if  ( &BLANK%parameter_infile 1 
@ @ &parameter_infile_l 
end i f  
i f  ( &BLANK%parameter_infile 2 
@ @ &parameter_infi le_2 
end i f  
if  ( &BLANK%parameter_infile 3 
@ @ &parameter_infile_3 
end i f  
if  ( &BLANK%parameter_infile_4 
@ @ &parameter_infile 4 
end i f  
i f  ( &BLANK%parameter_infile 5 
@ @ &parameter_infi le_S 
end i f  
end 
xray 
fal se ) then 
false ) then 
fal se ) then 
fal se ) then 
fal se ) then 
@ CNS_XTALLIB : spacegroup . l ib ( sg=& sg ;  
sgparam= $sgparam; ) 
a=&a b=&b c=&c alpha= &alpha beta=&beta gamma=&gamma 
@CNS XRAYLIB : scatter . lib 
i f  ( &BLANK%reflection_infi le_l = fa lse ) then 
reflection @ @ & reflect ion infile 1 end 
end i f  
i f  ( &BLANK% reflection_infile_2 = false ) then 
reflection @ @ & reflection infi le 2 end 
end i f  
- -
if  ( &BLANK%re flect ion_infile_3 = fal se ) then 
reflection @ @ & reflection infi le 3 end 
end i f  
end 
if ( &BLANK%anom_l ibrary 
@ @ &anom_l ibrary 
else 
set echo=off end 
xray anomalous =? end 
false ) -then 
i f  ( $ result = true ) then 
display Warning : no anoma lous l ibrary has been specif ied 
display no anomalous cont ribut ion wi l l  used in re finement 
end i f  
s e t  echo=on end 
end i f  
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{ - copy define parameters of  optional arrays into symbol s  so 
we can rede fine them - }  
evaluate ( $obs_i=&obs_i ) 
evaluate ( $ obs_sigi=&obs sigi ) 
evaluate ( $ obs_w= &obs_w) 
xray 
@ @CNS_XTALMODULE : checkre finput 
reftarget= & re ftarget ; 
obs f=&obs f ;  
obs_sigf=&obs_s igf ;  
te st_set=&test_set ;  
obs_pa=&obs_pa ; 
obs_pb=&obs_pb ; 
obs_pc=&obs_pc ; 
obs_pd=&obs_pd;  
obs_phase= &obs_phase ; 
obs_fom= &obs_fom; 
obs_w=$obs_w; 
obs_i=$obs_i ; 
obs_s igi=$obs sigi ; 
) 
query name=fcalc domain=reciprocal end 
if ( $ obj ect_exist = false ) then 
declare name=fcalc domain=reciprocal type=complex end 
end if  
declare name=fbulk  domain=reciprocal type=complex end 
do ( fbul k=0 )  ( al l ) 
binresolution &low res &high_res 
mapre solution &high_res 
if ( &obs_type = " intens ity" ) then 
if ( &BLANK%obs i = true } then 
display Error : observed intensity  array is undefined 
display aborting s cript 
abort 
end if 
evaluate ( $ rej ect_obs= &obs_i ) 
evaluate ( $ rej ect_sig=& obs_s igi ) 
show min ( amplitude ( & STRI P%obs_i ) )  (all ) 
evaluate ( $obs lower_limit=$ result- 0 . 1 ) 
else 
evaluate ( $ rej ect_obs= &obs_f ) 
evaluate ( $ rej ect_s ig=&obs_s igf ) 
evaluate ( $obs_lower limit=0 )  
end i f  
declare name=ref act ive domain=reciprocal type=integer end 
declare name=tst  active domain=reciprocal type=integer end 
do ( re f_active=0 )  ( all  
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do ( re f_active=l )  
$obs_lowe r_l imit ) and 
amplitude ( $ STRI P%rej ect_obs ) > 
& low res >= d >= &high_res 
stati stics ove rall 
completeness  
selection= ( re f_active= l 
end 
evaluate ( $ total_compl= $expres s ionl ) 
show sum ( l )  ( re f_active=l ) 
evaluate ( $ total read=$ select )  
evaluate ( $total=theor=int ( l . / $ total_compl * $total read) } 
show rms ( ampl itude ( $ STRI P% rej e ct_obs ) )  
evaluate ( $ obs_high=$result* &obs_rms ) 
show min ( ampl itude ( $STRI P% rej ect_obs ) )  
evaluate ( $obs_low=$ result ) 
do ( re f_active=O )  ( all ) 
do ( ref  active=l )  
re f active=l 
re f active=l 
- ( ( ampl itude ( $STRI P% rej ect_obs )  >= 
&s igma cut*$STRIP%rej ect sig ) and 
- ( $STRI P%rej ect_sig # 0 )  and 
( $ obs_low <= amplitude ( $ STRI P%re j ect_obs ) <= 
$ obs_high ) and 
& low res >= d >= &high_re s ) ) 
do ( tst_active=O )  ( all ) 
i f  ( &BLANK%test_set = false ) then 
do ( tst_active=l )  ( ref_active=l and &STRIP%test_set= &test_flag ) 
end i f  
show sum ( 1 )  ( r e f  active= l and tst  active=O 
evaluate ( $total_work=$ select ) 
show sum ( l )  ( re f_active= l and tst  active=l 
evaluate ( $total_test=$ select ) 
evaluate ( $total_used=$total_work+$total_tes t )  
evaluate ( $unobserved=$ total theor-$ total read) 
evaluate ( $ rej ected=$total read-$total used) 
evaluate ( $per unobs =l 0 0 * ($unobserved/$total theor ) )  
evaluate ( $per-rej ect=l 0 0 * ( $ rej ected/ $total theor ) ) 
evaluate ( $per-used= l 0 0 * ( $total used/ $total-theor) ) 
evaluate ( $per-work=l 0 0 * ( $ total-work/ $total-theor ) ) 
evaluate ( $per=test=10 0 * ( $total=test / $ total=theor ) ) 
associate fcal c ( &atom_select 
tselection= ( ref_act ive=l )  
cvselection= ( tst active= l 
method=FFT 
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fft 
if ( & fft_memory < 0 )  then 
automemory=true 
else 
memory=& fft_memory 
end i f  
end 
tolerance=0 . 0  lookup=false 
if  ( &wa >= 0 )  then 
wa= &wa 
end if 
end 
if ( &BLANK%ncs infile 
inline @ &ncs infile 
end i f  
fal se ) then 
if ( &BLANK%restraints infile 
@ &restraints infile 
end i f  
do ( s tore9=0 ) ( al l )  
evaluate ( $nal t=l )  
evaluate ( $ alt=l )  
evaluate ( $ done=fal se ) 
fal se ) then 
while ( $done = fal se ) loop nalt 
i f  ( &exi st_conf_$ alt = t rue ) then 
show sum ( l )  ( & conf_$ alt ) 
i f  ( $ result > 0 )  then 
evaluate ( $nalt=$nalt+l ) 
end i f  
else 
evaluate ( $done=true ) 
evaluate ( $nalt=$nalt- 1 )  
end i f  
evaluate ( $ alt=$ alt+ l )  
end loop nalt 
evaluate ( $ alt=l )  
while ( $alt <= $nalt ) loop alt 
do ( s tore 9=$alt ) ( & conf_$alt  
evaluate ( $ alt=$alt+ l )  
end loop alt 
igroup 
interaction ( &atom_select and not ( attr store9 > 0 ) ) 
( &atom_select and not ( attr store 9 > 0 ) ) 
evaluate ( $ alt=l ) 
while ( $ alt <= $nalt ) loop ales 
interaction ( & atom select and ( attr store 9  $alt or  attr store 9  
0 ) ) 
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( &atom_select and ( attr s tore 9 
evaluate ( $a lt=$alt+ l )  
end loop ales  
end 
$alt  ) ) 
{ - check i solated atoms and atoms at special positions and add to 
list of fixed atoms if needed - store9 will be used - }  
@CNS_XTALMODULE : setupfixed ( 
mode= "minimi z ation" ; 
atom_select=& atom_select ; 
atom_fixed= &atom_fixed; 
atom_tota l_fixed=store 9 ;  
atom_multipli city=rmsd; 
) 
fix selection= ( store9 ) end 
fas tnb grid end 
flags 
exclude elec inc lude pvdw xre f 
? 
end 
show sum ( l )  ( & atom_harm) 
if ( $ resul t > 0 )  then 
evaluate ( $harmonic=true ) 
else 
evaluate ( $harmonic=false ) 
end i f  
xray 
predict 
mode=reciprocal 
to=fcalc 
selection= ( ref_act ive=l )  
atomselect ion= ( &atom select 
end 
end 
@ @ CNS_XTALMODULE : s calenbulk  (bscale= &bs cale ; 
sel= ( ref_act ive=l ) ;  
sel_test= ( tst_active=l ) ;  
re s_bscale= & low_res_bscale ; 
atom_select= ( &atom_s elect ) ;  
bul k_sol=&bulk_sol ; 
bul k_mas k=&bulk_mas k_infile ; 
bu lk_atoms= ( &atom_select ) ;  
sol_k=& sol_k; 
so l_b=& sol_b;  
fcalc=fcal c ;  
fobs= &STRI P%obs f ;  
sigma=& STRI P% obs_sigf ; 
iobs= $STRI P %obs_i ; 
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sigi =$STRI P%obs s igi ; 
fpart=fbul k ;  
B2 1 1=$ aniso 1 1 ;  
B2=2 2 =$ ani so=2 2 ;  
B2_3 3=$aniso_3 3 ;  
B2_12=$ ani so_1 2 ;  
B2_1 3=$ ani so_13 ;  
B2_2 3=$ani so_2 3 ;  
trace=$trace ; 
so l_k_re f= $sol_k_re f ;  
sol_b_re f=$sol_b_re f;  
b_to o_low=$l ow_b_flag ; ) 
if  ( $harmonic = true then 
do ( refx=x )  ( al l )  
do ( refy=y) (all ) 
do ( refz = z )  ( al l )  
do (harm=0 )  ( a l l )  
do ( harm=& k_harmoni c )  ( �atom harm)  
flags include harm end 
end i f  
xray 
end 
@ @ CNS XTALMODULE : calculate r ( fobs= &STRI P%obs_f ; 
fcalc=fcal c ;  
fpart= fbulk;  
sel= ( ref_active=l ) ; 
sel_te st= ( tst_active= l ) ; 
print=true ; 
output=OUTPUT ; 
r=$ start_r ;  
test_r=$start_test_r ; ) 
evaluate ( $ cycle=l )  
while ( $cycle <= &num_cycles ) loop main 
xray 
@ @CNS_XTALMODULE : refinementtarget ( target=& reftarget;  
s ig_s igacv= 0 . 07 ;  
mbins=&target_bins ; 
fobs= &STRI P%obs_f ; 
sigma=&STRIP%obs_sigf;  
weight=$STRI P%obs_w;  
iobs=$STRIP%obs_i ; 
sigi=$STRI P%obs_s igi ; 
test=tst_active ; 
fcalc=fcalc ;  
fpart=fbulk ;  
pa=& STRI P %obs_pa ; 
pb= &STRI P%obs_pb ; 
pc=&STRI P%obs_pc ; 
pd=&STRI P%obs_pd; 
phase=&STRI P%obs_phase ; 1 00 
end 
i f  ( &wa < 0 )  then 
@ @CNS_XTALMODULE : getweight 
fom=& STRI P%obs fom; 
sel = ( re f_active=l ) ; 
sel_test= ( tst_active=l ) ; 
s tati stics=true ; ) 
selected=& atom_select ; 
fixed= ( s tore 9 ) ; 
) 
end i f  
i f  ( &minimi ze_nstep > 0 )  then 
minimi z e  lbfgs 
nstep= &minimi ze_nstep 
nprint=S 
drop=l 0 . 0  
end 
end i f  
evaluate ( $ cycle=$ cycle+l ) 
end loop main 
xray 
predict 
mode=reciprocal 
to=fcalc 
selection= ( re f_active=l )  
atomselection= ( &atom_select 
end 
@ @ CNS_XTALMODULE : calculate_r ( fobs =& STRI P%obs f ;  
fcalc=fcal c ;  
fpart=fbulk ;  
sel= ( re f_active=l ) ; 
sel_test= ( t st_act ive=l ) ; 
print=true ; 
output=OUTPUT ; 
r=$ full_r ; 
tes t_r= $ ful l_test_r ; )  
end 
print thre shold=2 0 . 0  bond 
evaluate ( $rmsd_bond=$ resul t )  
print threshold=S0 . 0  angle 
evaluate ( $ rmsd_angle=$result )  
set  display= &coo rdinate_outfile end 
display REMARK coordinates from min imi z ation refinement 
di splay REMARK refinement resolution : & low res - &high_res A 
i f  ( $total_test > 0 )  then 10 1  
display REMARK starting r= $ start_r [ f6 . 4 ]  free r= 
$ start_te st_r [ f 6 . 4 ]  
display REMARK final r= $ full_r [ f6 . 4 ]  free_r= $ full  test r [ f6 . 4 ] 
else  
display REMARK starting r= $s tart_r [ f6 . 4 ]  
display REMARK final r= $ full_r [ f 6 . 4 ] 
end i f  
di splay REMARK rms d bonds= $ rmsd_bond [ f 8 . 6 ] rmsd angles= 
$rmsd_angle [ f8 . 5 ] 
xray wa= ? end 
evaluate ( $wa print=$resul t )  
di splay REMARK wa= $wa_print 
display REMARK target= &STRI P%reftarge t cycles= &num_cycles steps = 
&minimi ze_ns tep 
di splay REMARK sg= &STRI P%sg a= &a b= &b c= &c alpha= &alpha beta= 
&beta gamma= &gamma 
if ( &BLANK%parameter_infile_l = false ) then 
di sp lay REMARK parameter file 1 : &STRI P%parameter_infile 1 
end i f  
if  ( &BLANK%parameter_infile_2 = false ) then 
di splay REMARK parameter file 2 : &STRI P%parameter_infile 2 
end if  
if ( &BLANK%parameter_infile_3 = false ) then 
di spl ay REMARK parameter file 3 : &STRI P%parameter_infile 3 
end i f  
i f  ( &BLANK%parameter_infile_4 = fal se ) then 
di sp lay REMARK parameter file 4 : &STRI P%parameter_infile 4 
end i f  
i f  ( &BLANK%pa rame ter_infile_5 = fal se ) then 
di splay REMARK parameter file 5 : &STRI P%parameter_in file 5 
end if  
display REMARK molecular structure file : &STRI P% structure infile 
display REMARK input coordinates :  &STRI P%coordinate_in file 
if ( &BLANK%anom_l ibrary = false ) then 
display REMARK anomalous f '  f ' ' library : &STRI P% anom_l ibrary 
end i f  
if ( &BLANK%reflection_infi le_l = false ) then 
display REMARK re flection file= &STRI P%reflection infile 1 
end if  
if ( &BLANK%re flecti on_infile_2 = false ) then 
display REMARK reflection file= &STRIP%reflection infile 2 
end i f  
if ( &BLANK%reflection_infile_3 = false ) then 
display REMARK reflection file= &STRI P%re flection infile 3 
end i f  
i f  ( &BLANK%restraint s_infile = fal se ) then 
display REMARK addi tional restraints file : &STRIP%restraints infi le 
end i f  
i f  ( &BLANK%ncs_infile = false ) then 
display REMARK ncs= &STRI P%ncs_type ncs file= &STRI P%ncs infile 
else 
display REMARK ncs = none 
end i f  
i f  ( &bscale # " no " ) then 
display REMARK B-correction resolution : &low res bs cale - &high_res 102 
i f  ( $ low_b_fl ag = true ) then 
di splay REMARK warning : B-correction gave atomic B-values less 
than zero 
display REMARK they have been reset to zero 
end i f  
end i f  
i f  ( &bscale = " anisotropic"  ) then 
display REMARK initial B- factor correction appl ied to &STRI P%obs f 
display REMARK Bl 1=$ ani so_l l [ f8 . 3 ] B2 2=$aniso_2 2 [ f 8 . 3 ]  
B33=$ aniso_33 [ f8 . 3 ] 
display REMARK 
B23=$aniso_2 3 [ f 8 . 3 ]  
Bl2=$aniso_1 2 [ f8 . 3 ] B1 3=$aniso_13 [ f 8 . 3 ]  
di splay REMARK B- factor correct ion appl ied t o  coordinate array B :  
$trace [ f8 . 3 ] 
= " anisotropic_fixed_i sotropic " ) then elsei f ( &bscale 
display REMARK 
display REMARK 
B33=$ani so_3 3 [ f8 . 3 ]  
initial B-factor correction appl ied t o  & STRI P%obs f 
B1 1=$ aniso_l l [ f8 . 3 ] B2 2 =$ani so�2 2 [ f 8 . 3 ] 
display REMARK 
B23=$aniso_2 3 [ f 8 . 3 ] 
B12 =$ani so_1 2 [ f8 . 3 ] Bl 3=$aniso_1 3 [ f 8 . 3 ] 
display REMARK no B- factor correction applied to coordinate array B 
elseif ( &bscale = " i sotropic"  ) then 
display REMARK B- factor correction appl ied to coordinate array B :  
$trace [ f8 . 3 ]  
else 
display REMARK initial B- factor correction : none 
end i f  
i f  ( &bulk_sol = true ) then 
di splay REMARK bul k  solvent : density leve l= $sol_k_ref e /AA 3 ,  B­
factor= $ sol  b re f AA 2 
else 
display REMARK bulk solvent : false 
end if  
if  ( &obs_type = " intensity" then 
display REMARK reflections with I obs /sigma_I < & sigma_cut rej ected 
display REMARK reflections with I obs > &obs_rms * rms ( Iobs ) rej ected 
else 
display REMARK re flections with I Fobs l / sigma_F < & sigma_cut rej ected 
display REMARK reflections with I Fobs l > &obs rms * rms ( Fobs ) 
rej ected 
end i f  
xray anomalous =? end 
if ( $ result = true ) then-
di splay REMARK anomalous di ffract ion data was input 
end i f  
display REMARK theoretical total number of  refl . i n  resol . range : 
$total_theor [ I 6 ] ( 1 0 0 . 0 % ) 
di splay REMARK number of unobserved reflect ions (no entry or I F l =0 ) : 
$unobserved [ I 6 ]  ( $per_unobs [ f5 . 1 ] % ) 
display REMARK number of reflections rej ected : 
$rej ected [ I 6 ] ( $per_rej ect [ f5 . 1 ] % ) 
di splay REMARK total number of reflections used : 
$total_used [ I 6 ]  ( $per_used [ f5 . 1 ]  % ) 
di splay REMARK number of reflections in working set : 
$total_work [ I 6 ]  ( $per_work [ f5 . 1 ] % ) 1 03 
display REMARK number of  ref lect ions in test set : 
$total_test [ I 6 ]  ( $per_test [ f 5 . 1 ] % ) 
remark 
@CNS_XTALMODULE : write_pd.b (pd.b_o_format=&pd.b_o_format ; 
stop 
CNS 2Fo-Fc map 
coordinate outfile=& coordinate_out file ; 
sgparam=$sgparam; ) 
{ +  file : map . inp + }  
{ +  directory : xtal_re fine + }  
{ +  des cription : Make an e lectron density map us ing phase information 
from a model + }  
{ +  comment :  
phi calc ) ) 
choice of  coe fficient s : 
( u  m l Fo l  eA ( i  phi_cal c ) ) - (v  D I Fc l  eA ( i  phi_cal c ) ) 
(u  I Fo l  e A ( i  phi_cal c ) ) - (v k l Fc l  e A ( i  phi_cal c ) ) 
(u  m l Fo l  eA ( i  phi_comb ) ) - (v D I Fc l  e A ( i  phi_cal c ) ) 
( u  m_obs l Fo l  e A ( i  phi_obs ) )  - (v k m_obs l Fc l  e A ( i  
d ( target ) /dFc 
where Fe is the cal culated structure factor and 
m and D are derived from sigmaa 
Averaging of structure factors from several models 
opt ional . 
Real space R-value calculation optional . + }  
{ +  authors : Axel T .  Brunge r and Paul D .  Adams + }  
{ +  copyright : Yale University + }  
{ +  reference : R . J .  Read, Improved Fourier coe ffi cients for maps us ing 
phas es from partial structures with errors . Acta Cryst . 
A4 2 ,  1 4 0 - 1 4 9 ( 1 9 8 6 )  + }  
{ +  reference : G . J . Kleywegt and A . T .  Brunger , Checking your 
imagination : 
Appli cations of  the free R value , St ructure 4 ,  
8 97 - 9 0 4  ( 1 9 9 6 )  + }  
{ +  reference : A . T .  Brunge r ,  P . D .  Adams and L . M .  Rice , New applications 
of s imulated anneal ing in X- ray crystallography and 
solut ion NMR, Structure 5 ,  3 2 5 - 3 3 6 ,  ( 1 9 9 7 )  + }  
{ - Guidel ines for us ing this  file : 
- all strings must be quoted by double-quotes 
- logical variables ( true / fals e )  must not be quoted 
- do not remove any evaluate statements from the file - }  
{ - begin block parameter de finition - }  de fine ( 
{ ======================= molecular st ructure ------------------------- } 
{ *  molecular topology file * }  
{ ===> }  structure_infile= "gen8 . psf " ; 
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{ *  parameter files * }  
{ ===> }  parameter_infile_l = "CNS_TOPPAR : protein_rep . param" ; 
{ ===> }  parameter_infile_2 = "CNS_TOPPAR : water_rep . param" ; 
{ ===> }  parameter_infile_3= " cd_xplor_par . txt " ;  
{ ===> }  parameter_infile_4 = " ci s_peptide . param" ; 
{ ===> }  parameter_infile_S= " " ;  
{ *  coordinate files * }  
{ *  structure factors from multiple coordinates sets will be averaged * }  
{ ===> }  coordinate_infile_l = "bref . pdb " ; 
{ ===> }  coordinate infile 2 = " 
{ ===> }  coordinate infile 3 =" 
{ ===> }  coordinate infile 4 =" 
{ ===> }  coordinate infile 5= " 
{ ===> }  coordinate infile 6= " 
{ ===> }  coordinate infile 7 = " 
{ ===> }  coordinate infile 8= " 
{ ===> }  coordinate_infile_9= " 
{ ===> }  coordinate infile 1 0= " ;  
{ ====================== crystallographic data ======================== } 
{ *  space group * }  
{ *  use I nternational Table conventions with subs cripts subs tituted 
by parenthesis * }  
{ ===> }  sg= " P4 ( 1 ) " ;  
{ *  unit cell parameters in  Angstroms and degrees * }  
{ +  table : rows= l " cel l "  cols= 6 " a "  "b"  " c "  " alpha " "beta " " gamma " + }  
{ ===> }  a=7 3 . 57 7 ;  
{ ===> }  b=7 3 . 57 7 ; 
{ ===> }  c= 92 . 2 98 ; 
{ ===> }  alpha=9 0 ; 
{ ===> }  beta= 90 ; 
{ ===> }  gamma=9 0 ; 
{ *  anomalous f '  f ' ' library file * }  
{ *  I f  a file i s  not speci fied, no anomalous contribution will  be 
included * }  
{ +  choice : " CNS XRAYLIB : anom cu . l ib" "CNS XRAYLIB : anom mo . l ib " " "  
user_file + }  
{ ===> }  anom_library= " " ;  
{ *  reflection files * }  
{ *  specify non-anomalous reflection files before anomalous reflection 
files . * }  
{ *  files must contain unique array names otherwise errors will occur * }  
{ ===> }  reflection_infile_l =" j to2 . hkl " ;  
{ ===> }  reflection_infile_2 =" " ;  
{ ===> }  reflection_infile_3= " " ;  
{ *  reciprocal space array containing observed amplitudes : required * }  
{ ===> }  obs_f= " fobs " ; 1 05 
{ *  reciprocal space array containing sigma value s for ampl itudes : 
required * }  
{ ===> }  obs_s igf=" sigma" ; 
{ *  reciprocal space array containing te st set for cross-validation : 
required for calculation of  cross -val idated s igmaA values * }  
{ ===> }  test_set=" test " ; 
{ *  number for selection o f  test reflections : required for cross­
val idation * }  
{ *  ie . re flections with the test set array equal to thi s number will be 
used for cross-validation,  al l othe r reflections form the 
working set * }  
{ ===> }  test_flag= l ;  
{ *  reciprocal space array containing weighting s cheme for observed 
amplitudes : optional * }  
{ *  only used for the " res idual " and "vector"  targets - this will 
default to a cons tant value of  1 i f  array is not present * }  
{ ===> }  obs_w= " " ;  
{ *  reciprocal space array containing observed intensities : optional * }  
{ *  required for the "ml i "  target * }  
{ ===> }  obs_i= " " ;  
{ *  reciprocal space array containing sigma values for intensities : 
optional * }  
{ *  required for the "ml i "  target * }  
{ ===> }  obs sigi=" " ;  
{ *  reciprocal space arrays with experimental phase probabil ity 
distribution : optional * }  
{ *  Hendrickson-Lattman coeffi cients A, B , C , D * }  
{ *  required for the "mlhl " target and phase comb ined or  observed maps 
* }  
{ +  table : rows = l " HL coefficient s "  col s =4 "A" " B "  " C "  " D" + }  
{ ===> }  obs_pa= " " ;  
{ ===> }  obs_pb= " " ;  
{ ===> }  obs_pc= " " ;  
{ ===> }  obs_pd= " " ;  
{ *  complex reciprocal space array containing experimental phases : 
optional * }  
{ *  required for the "mixed" and "vector" targets * }  
{ ===> }  obs_phase= " fobs " ;  
{ *  reciprocal space array containing experimental figures o f  merit : 
optional * }  
{ *  required for the "mixed" target * }  
{ ===> }  obs_fom= " fom" ; 
{ *  resolution l imits for data included in map calculation * }  
{ *  all data available should be included in the map calculation * }  
{ +  table : rows =l " resolution "  col s=2 " l owe st"  "highest" + }  
{ ===> }  low_res=l O O ;  1 06 
{ ===> }  high_res =l . 8 ; 
{ *  apply rej ection criteria to amplitudes or intensities * }  
{ +  choice : " amplitude " " intens ity" + }  
{ ===> }  obs_type= " ampli tude " ;  
{ *  Observed data cutoff criteria : applied to amplitudes or intensities  
* }  
{ *  reflections with magnitude (Obs ) / sigma < cutoff are rej ected . * }  
{ ===> }  sigma_cut=0 . 0 ; 
{ *  rms outlier cutoff : applied to amplitude s or intensities * }  
{ *  reflections with magnitude ( Obs ) > cutoff*rms ( Obs ) wi l l  be rej ected 
* }  
{ ===> }  obs_rms=l 0 0 0 ; 
{ =================== non-crystallographic symmetry ------------------- } 
{ *  NCS-re straints/constraints file * }  
{ *  see auxiliary/ncs . de f  * }  
{ ===> }  ncs_infile=" " ;  
{ ------------ initial B-factor and bul k  solvent corrections ---------- } 
{ *  initial B-factor correction * }  
{ +  choice : " no "  " i sotropi c "  " anisot ropi c "  " ani sotropic_fixed_i sotropic "  
+ }  
{ ===> }  bscale= " anisot ropi c " ; 
{ *  lower resolution limit for B- factor correction * }  
{ *  the co rrection can only be calculated us ing data t runcated at a 
lower resolution limit of  between 8 and 6 A .  The correction wil l be 
appl ied to all  reflections * }  
{ ===> }  low_res_bs cale= 6 . 0 ; 
{ *  bulk  solvent correction * }  
{ *  a mas k is  required around the molecule ( s ) . The region 
outs ide thi s mas k is  the solvent region * }  
{ +  choice : true false + }  
{ ===> }  bulk_sol =true ; 
{ *  bulk  solvent mask  file * }  
{ *  mask  will be read from O type mas k  file i f  a name is given 
otherwi se calculated from coordinate s of selected atoms * }  
{ ===> } bul k_mas k_infile= " " ;  
{ *  solvent density leve l * }  
{ *  i f  negative , determined automatically  
i f  po sitive , fixed at value given * }  
{ ===> }  sol_k=- 1 ;  
{ *  solvent B- factor * }  
{ *  i f  negative , determined automatically 
i f  pos itive ,  fixed at value given * }  
{ ===> }  sol_b=-1 ;  
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{ -------------------------- atom selection --------------------------- } 
{ *  select atoms to be included in map calculation * }  
{ ===> }  atom_select= ( known and not hydrogen ) ;  
{ ==================== map generation parameters ====================== } 
{ *  maps are cal culated u*Fo - v*Fc * }  
{ *  eg . 2 fo-fc map -> u=2 and v=l or 
fo- fc map -> u=l and v=l * }  
{ *  speci fy u * }  
{ ===> } u=2 ;  
{ *  speci fy v * }  
{ ===> }  v=l ;  
{ *  type o f  map * }  
{ +  list : sigmaa : ( u  m l Fo l  - v D I Fc l ) A exp ( i  phi_cal c )  
m and D calculated from sigmaa 
unweighted : (u I Fo l  - v k l Fc l ) Aexp ( i  phi_cal c )  
n o  figure-of-merit weighting 
combined : (u m l Fo l A exp ( i  phi_comb ) - v D I Fc l Aexp ( i  phi_cal c ) ) 
model and experimental phases  combined, m and D 
from sigmaa 
observed : (u m l Fo l Aexp ( i  phi_obs )  - v k m l Fc l A exp ( i  phi_calc ) )  
observed phases and fom from phase probability 
dis tribution 
gradient : d ( target ) /dFc 
gradient of the current crystallographic target wrt 
Fe 
NB . experimental phases must be supplied as a phase 
probability di s tribution in the Hendrickson-Lattman arrays 
+ }  
{ +  cho ice : " s igmaa " "unweighted" " combined" " observed" " gradient " + }  
{ ===> }  map_type= " s igmaa " ;  
{ *  refinement target - only used for gradient maps * }  
{ +  list : ml f :  maximum likel ihood target us ing amplitudes 
ml i : maximum l i ke lihood target using intensities 
mlhl : maximum l i kel ihood target us ing amplitudes 
and phase probability distribution 
residual : s tandard crystallographic residual 
vector : vecto r residual 
mixed : ( 1 - fom) * residual + fom*vector 
e2e2 : correlation coeffi cient us ing normal i zed E A 2 
elel : correlation coefficient using normal i zed E 
f2 f2 : correlation coe fficient using FA 2 
f l f l : correlation coe fficient using F + }  
{ +  choice : "ml f "  "ml i "  "mlhl " " res idual"  "vector "  "mixed" 
" e2e2 " " e lel " " f2 f2 "  " fl f l "  + }  
{ ===> }  reftarget= "ml f " ; 
{ *  number of  bins for refinement target * }  
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{ *  thi s will be determined automatical ly i f  a negative value is given 
otherwise the speci fied number of bins will be used * }  
{ ===> }  target_bins=- 1 ; 
{ *  use model amplitudes for unmeasured data * }  
{ *  thi s will not be applied to gradient or di fference maps * }  
{ +  choice : true fal se + }  
{ ===> }  fill  in=false ; 
{ *  scale map by dividing by the rms sigma of  the map * }  
{ *  otherwise map wi l l  be on an absolute fobs scale * }  
{ +  cho ice : true false + }  
{ ===> }  map_scale=true ; 
{ *  map format * }  
{ *  choice : " ens " " e zd" * }  
{ ===> }  map_format=" cns " ;  
{ *  map grid size : dmin*grid * }  
{ *  use grid=0 . 2 5 for better map appearance * }  
{ ===> }  grid=0 . 3 3 ;  
{ *  memory allocation for FFT calculation * }  
{ *  thi s will be determined automatically i f  a negative value is  given 
otherwise the speci fied number of words will  be alloca_ted * }  
{ ===> }  fft_memory=- 1 ;  
{ *  extent o f  map * }  
{ +  choice : "molecule"  " asymmetric" " unit " "box" " fract"  + }  
{ ===> }  map_mode= "molecule " ;  
{ *  select atoms around which map wil l  be written * }  
{ *  change i f  di fferent to atoms selected for map calculation * }  
{ ===> }  atom_map= ( known and not hydrogen ) ;  
{ *  cushion ( in Angstroms ) around selected atoms in "molecule"  mode * }  
{ ===> }  map_cushion=3 . 0 ;  
{ *  limits in orthogonal angstroms for box mode or 
fractional coordinates fo r fract mode * }  
{ +  table : rows=3 "x"  " y "  " z "  cols =2 "minimum" "maximum" + }  
{ ===> }  xmin=O . ;  
{ ===> }  xmax=O . ;  
{ ===> }  yrnin=O . ;  
{ ===> }  yrnax=O . ; 
{ ===> }  zmin=O . ;  
{ ===> }  zmax=O . ; 
{ ========================= real space R-value ------------------------- } 
{ *  calculate real space R-values * }  
{ +  choice : t rue fal se + }  
{ ===> }  real r=false ; 
{ *  select res idues for which real space R-values wi l l  be calculated * }  109 
{ ===> }  atom_real= ( known and not hydrogen ) ;  
{ --------------------------- output files ============================ } 
{ *  root name for output files * }  
{ +  list : 
map file will be in : <output_root> . map 
positive peaks in : <output_root>_positive . peaks 
negative peaks in : <output_root>_negative . peaks 
realspace R-value s in : <output_root>_r . l ist  
Fourier coefficients wil l  be  in : <output_root> . coe ff + }  
{ ===> }  output root= "bre f8 2 fofc " ; 
{ *  write map file * }  
{ +  choice : true false + }  
{ ===> }  write_map=true ; 
{ *  do peak picking on map * }  
{ *  optional - use water_pick . inp to pick wate rs * }  
{ +  choice : true fal se + }  
{ ===> }  peak_search=true ; 
{ *  number of  peaks to pick from map * }  
{ ===> }  peak_num=3 0 ;  
{ *  write a reflection file with the Fourier coe fficients o f  the map * }  
{ +  list : arrays written : 
map_fom : FOM weight applied to observed data 
map_phase : phases used for observed data 
map_s cale : scale factor appl ied to cal culated data 
map_coeff : Fourier map coefficients - map=ft (map_coe ff )  + }  
{ +  choice : t rue fal se + }  
{ ===> }  write_coef f= fal s e ;  
{ ====================================================================== 
===== } 
{ things below this l ine do not normally  need to  be changed 
} 
{ ====================================================================== 
===== } 
) { - end block parameter de finition - }  
{ checkvers ion 0 . 5 } 
evaluate ( $ log_level=quiet )  
structure @ &structure infile end 
coordinates @ &coordinate infile 1 
parameter 
- -
i f  ( &BLANK%parameter_infile 1 
@ @ &parameter_infile_l 
end i f  
false ) then 1 10 
i f  ( &BLANK%paramete r_infile_2 
@ @ &parameter_infile_2 
end i f  
i f  ( &BLANK%paramete r_infile_3 
@ @ &parameter_infi le_3 
end i f  
i f  ( &BLANK%parameter_infi le_4 
@ @ &parameter_infile 4 
end i f  
i f  ( &BLANK%parameter_infile_5 
@ @ &parameter_infile_S 
end i f  
end 
xray 
fal se ) then 
false ) then 
fal se ) then 
false ) then 
@ CNS_XTALLIB : spacegroup . l ib ( sg= &sg ; ) 
a=&a  b= &b c= & c  alpha= &alpha beta= &beta gamma=&gamma 
@ CNS XRAYLIB : scatter . l ib 
binresolution & low_res &high_res 
mapresolution &high_res 
generate & low_res &high_re s 
i f  ( &BLANK%re flection_infi le_l = false ) then 
reflection @ @ & reflection infile 1 end 
end i f  
- -
i f  ( &BLANK%re flection_infile_2 = false ) then 
reflection @ @ & reflection infile 2 end -
end i f  
- -
i f  ( &BLANK%reflection_infile_3 = false ) then 
reflection @ @ & reflection infile 3 end 
end i f  
end 
if  ( &BLANK%anom_l ibrary 
@ @ &anom_l ibrary 
else 
set echo=off end 
xray anomalous= ? end 
- -
false ) then 
if ( $result = t rue ) then 
display Warning : no anomalous library has been speci fied 
display no anomalous contribution wi l l  used in refinement 
end i f  
set echo=on end 
end i f  
{ - copy de fine parameters of  optional arrays into symbols so 
we can redefine them - }  
evaluate ( $obs_i =&obs i )  
1 1 1  
evaluate ( $obs_s igi=&obs sigi ) 
evaluate ( $obs_w=&obs_w )  
xray 
@ @CNS_XTALMODULE : checkre finput 
reftarget=& re ftarget ; 
obs_ f= &obs _ f ;  
obs_s igf=&obs_sigf;  
te st_set=&test_set ; 
obs_pa=&obs_pa ; 
obs_pb=&obs_pb ; 
obs_pc=&obs_pc ; 
obs_pd=&obs_pd; 
obs_phase=&obs_phase ; 
obs_fom= &obs_fom; 
obs_w=$obs_w; 
obs_i=$obs_i ; 
obs_s igi=$obs sigi ; 
) 
query name=fcalc domain=reciprocal end 
if ( $ obj ect_exi st = false ) then 
dec lare name= fcal c  domain=recipro cal type=complex end 
end i f  
declare name=fbul k  domain=reciprocal type=complex end 
do ( fbulk=0 )  ( al l ) 
query name=& STRI P%obs f domain=reciprocal end 
dec lare name=fobs_orig domain=reciprocal type=$ obj ect_type end 
dec lare name=sigma_orig domain=reciprocal type=real end 
do ( fobs_orig= &STRIP%obs_f ) ( a l l )  
do ( s igma_orig= &STRI P%obs sigf ) ( al l )  
i f  ( &BLANK%obs i = fal se ) then 
query name=& STRI P%obs_i domain=reciprocal end 
dec lare name=iobs_orig domain=reciprocal type=$obj ect_type end 
dec lare name=s igi_orig domain=reciprocal type=real end 
do ( iobs_orig= & STRIP%obs_i ) ( a l l )  
do ( s igi_orig= & STRIP%obs sigi ) ( al l )  
end i f  
i f  ( &obs type = " intensity" ) then 
if ( &BLANK%obs_i = true ) then 
display Error : observed intensity array is unde fined 
display aborting s c ript 
abort 
end i f  
evaluate ( $ rej ect_obs= &obs_i ) 
evaluate ( $ rej ect_s ig= &obs_s igi ) 
show min ( amplitude ( & STRIP%obs_i ) ) ( a l l )  
evaluate ( $obs lower_limit=$ result- 0 . 1 ) 
else 
evaluate ( $ rej ect_obs =&obs_f ) 
evaluate ( $ rej ect_s ig=&obs_s igf ) 
evaluate ( $obs lower_limit=0 )  
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end i f  
declare name=ref active domain=reciprocal type=integer end 
declare name=tst active domain=reciprocal type=integer end 
all do ( re f_active=O )  
do ( ref_active=l )  
$ obs_lower_l imit ) and 
( amplitude ( $ STRI P%rej ect_obs )  > 
& low res >= d >= &high_re s 
statistics overall  
completeness  
selection= ( ref_active=l 
end 
evaluate ( $ total_compl= $expression l )  
show sum ( l )  ( re f_active= l ) 
evaluate ( $ total read=$ select ) 
evaluate ( $ total=theor=int ( l . / $ total_compl * $total_read ) ) 
show rms ( amplitude ( $ STRI P%rej ect_obs ) ) 
evaluate ( $ obs_high=$result* &obs_rms ) 
show min ( amplitude ( $ STRI P%rej ect_obs ) )  
evaluate ( $ obs low=$ resul t )  
d o  ( re f_active=O )  ( a l l  ) 
do ( re f_active=l )  
ref acti ve=l ) · 
ref active= l 
( ( amplitude ( $ STRIP%rej ect_obs )  >= 
& sigma_cut* $ STRI P%rej ect_sig ) and 
( $ STRIP%rej ect_s ig # 0 )  and 
( $ obs_low <= amplitude ( $ STRIP%rej ect_obs ) <= 
$obs_high ) and 
& low res >= d >= &high_res ) ) 
do ( tst_active=O )  ( all ) 
if  ( &BLANK%test_set = false ) then 
do ( tst_active= l )  ( re f_active=l and & STRI P%test_set= &test_flag) 
end i f  
show sum ( l )  ( re f_active= l and tst active=O 
evaluate ( $ total_work= $ select ) 
show sum ( l )  ( re f_active= l and tst active= l 
evaluate ( $ total te st= $select ) 
evaluate ( $ total=used= $total_work+$total_tes t )  
evaluate ( $unobserved= $total_theor-$ total_read) 
evaluate ( $ rej ected=$total_read-$total_used) 
evaluate ( $per unobs= 1 0 0 * ( $unobserved/ $ total theor ) )  
evaluate ( $per-rej ect= 1 0 0 * ( $ rej ected/ $total theor ) ) 
evaluate ( $per-used= 1 0 0 * ( $ total used/ $total-theor ) ) 
evaluate ( $per-work= 1 0 0 * ( $ total-work/ $total-theor) ) 
evaluate ( $per=test= 10 0 * ( $ total=te st / $total=theor ) )  
as sociate fcalc ( & atom select 
1 1 3 
tselection= ( ref_active=l )  
cvselection= ( tst act ive=l 
inethod=FFT 
fft 
grid=&grid 
if ( & f ft_memory < 0 )  then 
automemory=t rue 
else 
memory= & f ft_memory 
end i f  
end 
tolerance=0 . 0  lookup=false 
end 
if ( &map_type = " observed" ) then 
evalaute ( $ test_hl=true ) 
elsei f ( &map_type = " combined" ) then 
evalaute ( $ test_hl=true ) 
else 
evalaute ( $ test_hl=fal se )  
end if  
if  ( $te st_hl = true ) then 
xray 
@ @CNS_XTALMODULE : check_abcd (pa= &obs_pa ; 
pb=& obs_pb ; 
pc=& obs_pc;  
pd=& obs _pd; ) 
end 
end i f  
if  ( &BLANK%ncs infile 
inline @ &ncs infile 
end if  
false ) then 
evaluate ( $ struct=l )  
eva luate ( $ done=fal se ) 
while ( $done = fal se ) loop struct 
if ( &exist_coordinate_infile_$ struct 
if ( &BLANK%coordinate_infile_$ struct 
evaluate ( $ done=true ) 
evaluate ( $ struct=$ struct- 1 )  
else 
evaluate ( $ struct=$struct+ l )  
end i f  
else 
evaluate ( $ done=true ) 
evaluate ( $ struct=$ struct- 1 )  
end i f  
end loop s truct 
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true ) then 
= true ) then 
evaluate ( $ave_cycle= $s truct ) 
evaluate ( $cycle=l )  
xray 
declare narne=dtarg dorna in=reciprocal type=cornplex end 
declare narne=fcave dornain=reciprocal type=cornplex end 
declare narne=fpave dornain=reciprocal type=cornplex end 
query narne=& STRI P%obs_f dornain=reciprocal end 
declare narne=foave dornain=reciprocal type=$ obj ect_type end 
declare narne=dave dornain=reciprocal type=cornplex end 
declare narne=total dorna in =reciprocal type=cornplex end 
declare narne=frnap dornain= reciprocal type=cornplex end 
do ( fcave=0 )  ( al l )  
do ( fpave=0 )  ( al l )  
do ( foave=0 )  ( al l )  
do ( dave=0 )  ( all ) 
end 
while $cycle <= $ ave_cycle ) loop main 
coord init end 
coord @ @ &coordinate_in file_$ cyc le 
xray 
do ( &STRI P%obs_f=fobs_orig)  ( al l )  
do ( &STRI P%9bs_s igf=sigrna_orig)  ( a l l )  
if  ( &BLANK% obs_i = fal se ) then 
do ( &STRI P%obs_i=iobs_orig)  ( a l l ) 
do ( &STRI P%obs_s igi =sigi_orig)  ( all ) 
end if  
end 
xray 
predict 
rnode=reciprocal 
to=fcalc  
selection= ( all ) 
atornselection= ( &atom select 
end 
end 
@ @ CNS_XTALMODULE : s calenbulk  (bscale= &bscale ; 
sel = ( ref_active=l ) ;  
sel_test= ( tst_active= l ) ;  
res_bscale= &l ow_res_bscale ;  
atorn_select= ( &atorn_select ) ;  
bul k_sol= &bul k_sol ; 
bul k_rnas k=&bulk_rnask_infile ; 
bul k_atorns= ( &atorn_s elect ) ;  
sol_k=&sol_k; 
sol_b=& sol_b ; 
fcalc= fcalc ;  
fobs= & STRI P%obs f ;  
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sigma= &STRI P%obs_s igf ; 
iobs=$STRI P%ob s_i ; 
sigi=$ STRI P%obs_s igi ; 
fpart=fbulk;  
B2 1 1=$aniso 1 1 ;  - -
B2_2 2=$aniso_2 2 ; 
B2_3 3=$aniso_3 3 ;  
B2_1 2 =$aniso_1 2 ;  
B2 1 3=$aniso 1 3 ;  
B2-2 3=$aniso=2 3 ;  
trace=$trace ; 
sol_k_re f=$sol_k_re f ;  
sol_b_re f=$sol_b_re f ;  
b_too low=$low_b_flag; ) 
xray 
if ( &map_type = " gradient " ) then 
@ @ CNS_XTALMODULE : refinementtarget ( target=& reftarget ; 
sig_sigacv=0 . 0 7 ;  
mbins= &target_bins ; 
fobs =& STRI P%obs f ;  
sigma= & STRI P%obs_s igf ; 
weight=$ STRI P%obs w ;  
iobs =$ STRI P%obs_i; 
s igi=$ STRI P%obs_s igi ; 
test=tst_active ; 
fcalc=fcalc ; 
fpart=fbulk;  
pa=& STRI P%obs_pa ; 
pb=& STRI P%obs_pb ; 
pc=& STRI P%obs_pc;  
pd=& STRI P%obs_pd; 
phase= & STRI P %obs_phas e ;  
fom= &S TRI P%obs_fom; 
sel= ( ref_act ive=l ) ; 
sel_test= ( tst_active= l ) ; 
statistics =true ; ) 
predict 
mode=dtarget ( fcal c )  
end 
to=dtarg 
selection= ( ref_active=l )  
atomselection= ( &atom_select 
do ( dave=dave+dtarg) ( al l )  
end if 
do ( fcave=fcave+fcal c )  ( a l l )  
do ( fpave=fpave+fbu l k )  ( al l )  
do ( foave=foave+&STRI P%obs f )  ( all ) 
end 
evaluate ( $ cycle= $cycle+l ) 
end loop main 
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i f  ( &map type = "gradient " ) then 
do ( dave=dave / $ ave_cycle ) ( al l )  
end i f  
do ( fcalc=fcave / $ ave cycle ) ( al l )  
do ( fbul k=fpave / $ ave-cycle ) ( al l )  
do ( &STRIP%obs_f=foa�e/ $ave_cycle ) ( al l ) 
@ @ CNS_XTALMODULE : cal cul ate_r ( fobs= & STRI P%obs f ;  
end 
xray 
fcal c=fcal c ;  
fpart=fbul k ;  
sel= ( re f_act ive= l ) ; 
sel_test= ( tst_active= l ) ; 
print=true ; 
output=OUTPUT ; 
r=$map_r ; 
test_r=$map_free_r ; )  
declare name=map_phase domain=reciprocal type=real end 
declare name=map_fom domain=reciprocal type=real end 
declare name=map_scale domain=reciprocal type=real end 
end 
if ( &map_type " unwe ighted" ) then 
xray 
do (map_phase=phase ( fcalc+ fbulk ) ) ( al l )  
do ( total =fcalc+fbul k )  ( al l )  
mul tiscale 
bfmin=- 4 0  bfmax=4 0  
setl = &STRI P%obs f 
set2=total 
kl =- 1  bl =0 
b2 =0 
selection= ( re f_active= l and d <= & low_res_bscale ) 
end 
do (map_scale=$ k2 )  ( al l )  
do (map_fom=l . 0 ) ( al l )  
end 
el sei f &map_type " sigmaa " ) then 
xray 
do (map_phase=phase ( fcalc+fbulk ) ) ( al l )  
declare name=m domain=reciprocal type=complex end 
declare name=mod fom domain=reciprocal type=real end 
declare name=mod x domain=reciprocal type=real end 
declare name=mod_pa domain=reciprocal type=real end 
declare name=mod_pb domain=reciprocal type=real end 
declare name=mod_pc domain=reciprocal type=real end 
decl are name=mod_pd domain=reciprocal type=real end 
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decl are name=mod dd domain=reciprocal type=real end 
@ CNS_XTALMODULE : foms igmaacv 
do (map_fom=mod_fom) ( a l l )  
( s i g  sigacv=0 . 07 ;  
mbins= & target_bin s ;  
statistics=true ; 
fobs= & STRI P%obs_f ; 
fcalc=fcal c ;  
fpart=fbulk;  
test=tst_active ; 
sel= ( ref_active=l ) ; 
sel_test= ( tst_active= l ) ; 
fom=mod_fom; 
x=mod_x ; 
pa=mod_pa ; 
pb=mod_pb ; 
pc=mod_pc;  
pd=mod_pd; 
dd=mod_dd; 
do (map_s cale=di stribute (mod_dd) ) ( & low_res >= d >= &high_res ) 
undeclare name=m domain=reciprocal end 
undeclare name=mod fom domain=reciprocal end 
undecl are name=mod x domain=reciprocal end 
undecl are name=mod_pa doma in=reciprocal end 
undeclare name=mod_pb domain=reciprocal end 
undeclare name=mod_pc domain=reciprocal end 
undeclare name=mod_pd domain=reciprocal end 
undeclare name=mod dd domain=reciprocal end 
end 
el sei f &map_type " combined" ) then 
xray 
declare name=m domain=reciprocal type=complex 
declare name=mod fom domain=reciprocal type=real end 
decl are name=mod x domain=reciprocal type=real end 
declare name=mod_pa domain=reciprocal type=real end 
declare name=mod_pb domain=reciprocal type=real end 
declare name=mod_pc domain=reciprocal type=real end 
declare name=mod_pd domain=reciprocal type=real end 
declare name=mod dd domain=reciprocal t ype=real end 
@CNS_XTALMODULE : foms igmaacv ( sig_s igacv=0 . 0 7 ;  
mbins= &target_bins ; 
s tati stics =true ; 
fobs= &STRI P%obs f ;  
fca lc=fcalc ; 
fpart=fbul k ;  
test=tst_active ; 
sel= ( ref_active=l ) ; 
sel_test= ( tst  active=l ) ; 
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end 
fom=mod_fom;  
x=mod_x ; 
pa=mod_pa;  
pb=mod_pb ; 
pc=mod_pc ; 
pd=mod_pd; 
dd=mod_dd; 
@CNS_XTALMODULE : combineprobabil ity rne ssage s= "off " ; 
addnarne= "rnodel phase s " ; 
pa=rnod_pa ; 
phases " ;  
pb=rnod_pb ; 
pc=rnod_pc ; 
pd=rnod_pd ; 
w= l ;  
addnarne= "experirnental 
adda= &STRI P%obs_pa ; 
addb=& STRI P%obs_pb; 
addc= &STRI P%obs_pc;  
addd= & STRI P%obs_pd; 
addw=l ; ) 
@CNS_XTALMODULE : getfom pa=mod_pa ; 
pb=mod_pb ; 
pc=mod_pc ; 
pd=mod_pd; 
m=m; 
phis tep=S ;  
do (rnap_phase=phase (rn) ) ( al l )  
do (rnap_forn=amplitude (m) ) ( a l l )  
do (rnap_scale=dist ribute (rnod_dd) ) ( & low_re s >= d >= &high_res ) 
undeclare narne=rn dornain=reciprocal 
undecl are narne=mod forn dornai n=reciprocal 
undeclare name=rnod x domain=re ciprocal 
unde clare name=mod_pa domain=reciprocal 
undeclare name=rnod_pb dornain=reciprocal 
undecl are narne=rnod_pc dornain=reciprocal 
undecl are narne=mod_pd dornain=reciprocal 
undeclare narne=rnod dd dornain=reciprocal 
end 
elseif &rnap_type " observed" ) then 
xray 
do ( total= fcalc+fbulk )  ( all ) 
rnultis cale 
bfmin=- 4 0  bfrnax=4 0  
setl =&STRIP%obs f 
set2 =total 
kl =-1  bl =0 
b2 =0 
end 
end 
end 
end 
end 
end 
end 
end 
selection= ( ref_act ive=l and d <= &l ow_res_bscale ) 
end 
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do (map_s cale=$ k2 )  ( al l )  
declare name=m doma in=reciprocal type=complex end 
@CNS_XTALMODULE : get fom pa= &STRI P%obs_pa ; 
pb= &STRI P%obs_pb ; 
pc= &STRI P%obs_pc ; 
pd= &STRIP%obs_pd;  
m=m; 
phi step=S ;  
do (map_phase=phase (m) ) (all ) 
do (map_fom=amplitude (m) ) ( all ) 
do (map_s cale=map_scale*map_fom) ( all ) 
undeclare name=m domain=re ciprocal end 
end 
end i f  
i f  ( &map_ type " gradient " ) then 
xray 
{ - take the negat ive of the gradient so the map is the same s ign 
as a standard di f ference map - }  
do ( fmap=-dave ) ( ref_active= l )  
do (map_fom= 0 . 0 ) ( ref_active=l )  
do (map_s cale=0 . 0 )  ( ref_active=l )  
do (map_phase= 0 . 0 )  ( ref_active=l )  
end 
else 
xray 
if ( &u = &v ) then 
do ( fmap= 2 ( ( &u map_fom 
combine ( amplitude ( & STRI P%obs_f) , map_phase) ) -
( &v map_s cale ( fcalc+fbul k ) ) ) )  
( ref_active=l and acent ric)  
do ( fmap= ( &u map_fom 
combine ( ampl itude ( & STRI P%obs_f ) , map_phase) ) -
else 
( &v map_s cale ( fcalc+ fbulk ) ) )  
( ref_active=l and centri c )  
d o  ( fmap= ( &u map_fom 
combine ( amplitude ( & STRIP%obs_f ) , map_phase) ) -
( &v map_s cale ( fcalc+ fbulk ) ) )  
( ref_act ive=l and acent ri c )  
do ( fmap= (max ( ( &u- 1 ) , 0 ) map_fom 
combine ( ampl itude ( & STRI P%obs_f ) , map_phase ) )  -
(max ( ( &v- 1 ) , 0 ) map_s cale ( fcalc+fbulk ) ) )  
( ref_active=l and centric )  
i f  ( & f i ll_in = true ) then 
do ( fmap= ( & u- &v)  map_s cale ( fcalc+fbul k ) ) 
( & low_res >= d >= &high_res and ref active # 1 )  
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end i f  
end 
end i f  
xray 
declare name=map domain=real end 
if ( &map_type = " gradient " ) then 
do (map= ft ( fmap ) ) ( ref_act ive=l )  
elseif ( &u = &v ) then 
do (map= ft ( fmap ) ) ( re f_act ive=l )  
elsei f ( & fill_in = true ) then 
do (map= ft ( fmap ) ) ( & low_res >= d >= &high_res ) 
else 
do (map=ft ( fmap ) ) ( ref_active=l )  
end if  
end 
if ( &write_coef f  = true ) then 
evaluate ( $coe ff_out=&output_root + " . coe ff " )  
xray 
declare name=map_coe ff domain=reciprocal type=complex end 
do (map_coeff=fmap ) ( al l )  
write re flection 
output=$ coeff_out 
if  ( &map_type = " gradient " ) then 
sele= ( re f_active=l )  
else i f  ( & fill_in = true ) then 
sele= ( &low_res >= d >= &high_res )  
else 
sele= ( re f_act ive=l )  
end i f  
map_fom map_phase map_scale map_coe ff 
end 
undeclare name=map_coef f  domain=reciprocal end 
end 
end i f  
xray 
undeclare name=map_phase domain=reciprocal end 
undeclare name=map_fom domain=reciprocal end 
undeclare name=map_s cale domain=reciprocal end 
end 
xray 
undecl are name=dtarg domain=reciprocal end 
undeclare name=fcave domain=reciprocal end 
undeclare name=fpave domain=reciproca l  end 
undeclare name=foave domain=rec iproca l end 
undeclare name=dave domain=rec iprocal end 
undeclare name=total domain=rec iprocal end 
undeclare name=fmap domain=reciprocal end 
end 
if ( &map_scale=true ) then 
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xray 
show rms ( real (map ) ) all 
do (map=map/ $resul t )  all 
end 
end i f  
if  ( &real_r = true ) then 
xray 
decl are name=mod_map domain=real end 
do (mod_map=ft ( fcal c+fbulk ) ) ( & low_res >= d >= &high_res ) 
i f  ( &map_scale=true ) then 
show rms ( real (mod map ) ) ( all  
do  (mod_map=mod_map/ $ resul t )  all  
end if 
declare name=corr_map 
declare name=mapll  
declare name=map1 2  
declare name=map2 2 
declare name=prop 
decl are name=di st 
declare name=mask 
end 
do ( store 9= 0 )  ( all ) 
evaluate ( $ counter=! )  
domain=real end 
domain=real end 
domain=real end 
domain=real end 
domain=real end 
domain=real end 
domain=real end 
for $ id in id ( tag and &atom real ) loop main 
do ( store 9= $counter ) ( byres ( id $ id) 
evaluate ( $ counter=$ counter+l ) 
end loop main 
xray 
mask 
mode=vdw 
solrad=0 . 1  
shrink=0 . 1 
nshell=l 
to=mask 
selection= ( &atom select 
end 
do (prop= O )  ( al l )  
proximity 
from=store 9 
distance_map=di st 
property_map=prop 
cutof f=3 . 0  
selection= ( &atom real 
end 
do (mapll =gave ( real (map ) * real (map ) , real (prop ) ) ) 
real (prop )  > 0 and real (mask )  <= 0 )  
do (map1 2 =gave ( real (map ) * real (mod_map ) , real (prop ) ) ) 
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0 )  
( real (prop ) > 0 and real (mask)  <= 0 
do (map22=gave ( real (mod_map ) * real (mod_map ) ,  real (prop ) ) ) 
( real (prop ) > 0 and real (mask)  <= 0 )  
do ( corr_map=real (map 12 ) / sqrt ( real (mapl l )  * real (map2 2 )  ) ) 
( real (prop) > 0 and real (mask )  <= 0 )  
end 
evaluate ( $ display= &output_root + "  r . lis t" ) 
set display=$display end 
display # resid segid cc R-value 
evaluate ( $ counter= l )  
for $id in i d  ( tag and &atom_rea l ) loop real 
xray 
show ave ( real ( corr_map ) ) ( real (prop) =$counter and real (mask )  <= 
end 
evaluate ( $corr=$ result ) 
evaluate ( $ realr= l - $ cor r )  
show ( resid)  ( i d  $id) 
evaluate ( $ resid=$ result ) 
show ( segid) ( i d $id )  
evaluate ( $ segid= $resul t )  
di splay $counter [ i 6 ]  $resid [ a4 ] 
$realr [ f6 . 3 ] 
$ segid [ a4 ] $ corr [ f 6 . 3 ] 
evaluate ( $counte r= $counter+l )  
end loop real 
xray 
undecl are name=mod_map domain=real 
undeclare name=corr_map domain=real 
undeclare name=mapl l domain=real 
undeclare name=map12  domain=real 
undeclare name=map2 2 domain=real 
undecl are name=prop domai n=real 
undeclare name=di st domain=real 
undeclare name=mask domain=real 
end 
end i f  
set remarks=reset end 
set remarks=accumulate end 
xray 
show s um ( 1 )  ( tst_act ive= l )  
i f  ( $ result > 0 )  then 
evaluate ( $tes t_exist=true ) 
else 
evaluate ( $test_exist=false )  
end i f  
end 
evaluate ( $ remark= " " )  
i f  ( $struct > 1 )  then 
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end 
end 
end 
end 
end 
end 
end 
end 
evaluate ( $ remark= " averaged " )  
end i f  
if  ( &map_type = " unwe ighted" ) then 
evaluate ( $ remark=$ remark + " ( " + encode ( &u )  + " I Fo l  - " +  
encode ( &v)  + "  k l Fc l ) e " ( i 
phi_cal c ) " )  
elsei f ( &map_type = " s igmaa " then 
evaluate ( $ remark=$ remark + " ( " + encode ( &u )  + " m l Fo l  - " +  
encode ( &v )  + " D I Fc l ) e " ( i 
phi_cal c ) " )  
i f  ( $ test_exi st = t rue ) then 
evaluate ( $ remark=$ remark + "  cros s-val . " ) 
end if  
evaluate ( $ remark=$ remark + "  s igmaa " )  
elseif  ( &map_type = " combined" ) then 
evaluate ( $ remark=$ remark + " ( " + encode ( &u )  + " m l Fo l ) e " ( i 
phi comb ) - " +  
" ( " + encode ( &v)  + "  D I Fc l ) e " ( i 
phi_calc ) " ) 
i f  ( $test_exist = t rue ) then 
evaluate ( $ remark=$ remark + " cros s-val . " ) 
end i f  
evaluate ( $ remark=$ remark + "  sigmaa " )  
elseif ( &map_type = " observed" ) then 
evaluate ( $ remark=$ remark + " ( " + encode ( &u )  + " m l Fo l ) e" ( i 
phi_obs ) - " +  
" ( " + encode ( &v )  + " k m l  Fe I )  e"  ( i  
phi_cal c ) ) " )  
el sei f ( &map_type = " gradient " ) then 
evaluate ( $ remark=$ remark + " (  d ( "  + & reftarget + " ) /dFc ) " ) 
end i f  
evaluate ( $ remark= $ remark + " map " )  
i f  ( $total_test > 0 )  then 
remark $remark r= $map_r [ f 6 . 4 ]  free r= $map free r [ f 6 . 4 ] 
else 
remark $ remark r= $map_r [ f 6 . 4 ]  
end i f  
if  ( &obs type = " intens ity" ) then 
remark re flections with I obs / s igma_I < &sigma_cut rej ected 
remark reflections with l obs > &obs rms * rms ( I obs ) rej ected 
else 
remark reflections with I Fobs l / sigma_F < & sigma_cut rej ected 
remark re flections with I Fobs l > &obs rms * rms ( Fobs ) rej ected 
end if 
xray anomalous= ? end 
if  ( $result = t rue ) then 
remark anomalous di ffraction data was input 
end if 
remark theoretical total number of  refl . in resol . range : 
$total_theor [ I 6 ]  ( 1 0 0 . 0  % ) 
remark number of  unobserved re flections ( no entry or  I F l =0 ) : 
$unobserved [ I 6 ]  ( $per_unobs [ f5 . 1 ] % ) 
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remark number of reflect ions rej ected :  
$rej ected [ I 6 ] ( $pe r_rej ect [ f5 . 1 ] % ) 
remark total number o f  re flections used : 
$total_used [ I 6 ]  ( $per_used [ f5 . 1 ] % ) 
remark number of reflections in working set : 
$total_wo rk [ I 6 ]  ( $per_work [ f5 . 1 ] % ) 
remark number of reflections in test set : 
$total_test [ I 6 ]  ( $per_test [ f5 . 1 ] % ) 
if  ( &bulk_sol true ) then 
remark bul k  solvent : dens ity leve l= $ sol_k_ref e /AA3 ,  B- factor= 
$ so l_b_re f  AA 2 
else 
remark bul k  solvent : false 
end i f  
if  ( &bscale # "no " ) then 
remark B-correct ion resolution : & low res bscale - &high_res 
else 
remark initial B- factor correct ion : none 
end i f  
if  ( &bscale = " ani sotropic " ) then 
remark initial B-factor correct ion appl ied to &STRIP%obs f 
remark Bl l= $aniso_l l B22 = $ ani so_2 2 B33= $ anis o_3 3 
remark Bl2 = $anise 1 2  B13 = $ anise 1 3  B2 3= $ anise 23  - - -
remark B-facto r correct ion appl ied to coordinate array B :  
$ trace [ f8 . 3 ]  
elseif ( &bscale = "anisotropic_fixed_anisotropi c"  ) then 
remark initial B-factor correction applied to &STRI P%obs f 
remark Bll= $anise 11 B22 = $ anise 22 B33= $ anise  33 
remark B12= $aniso=1 2 Bl3 = $ aniso=1 3 B23 = $ aniso=2 3 
remark no B- factor correction appl ied to coordinate array B 
elseif  ( &bscale = " i sotropic"  ) then 
remark B-factor correct ion appl ied to coordinate array B :  
$trace [ f8 . 3 ]  
end i f  
i f  ( &write_map = true ) then 
evaluate ( $ filename=&output_root + " . map " )  
i f  ( &map_mode = "asymmetric " ) then 
evaluate ( $map_mode_s tring=ASYM) 
elseif ( &map_mode = "unit " ) then 
evaluate ( $map_mode_s tring=UNIT )  
elsei f ( &map_mode = "box " ) then 
evaluate ( $map_mode_s tring=BOX) 
elseif  ( &map_mode = " fract " ) then 
evaluate ( $map_mode_string=FRAC ) 
else 
evaluate ( $map_mode_s tr ing=MOLE ) 
end if  
xray 
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write map 
i f  ( &map_format 
type=ezd 
else 
type=cns 
end if 
"e zd" ) then 
automatic=fal se 
from=map 
output=$ fi lename 
cushion=&map_cushion 
selection=&atom_map 
extend= $map_mode_s tring 
i f  ( &map_mode = "box" ) then 
xmin= &xmin xmax=&xmax 
ymin= &ymin ymax= &ymax 
zmin= & zmin zmax= & zmax 
end i f  
i f  ( &map_mode = " fract" ) then 
xmin= &xmin xmax=&xmax 
ymin= &ymin ymax= &ymax 
zmin= & zmin zmax= & zmax 
end i f  
end 
end 
end i f  
i f  ( &peak_search = true ) then 
evaluate ( $ filename= &output_root + "_pos itive . peaks " )  
xray 
peakpi k 
from=map 
mpeak=&peak_num 
se lection= ( all  
atom=true 
proximi ty= ( &atom_map )  
end 
end 
write coor output=$ filename selection= ( segid=PEAK ) end 
delete sele= ( segid=PEAK) end 
evaluate ( $ filename=&output_root + "___:negat ive . peaks " ) 
xray 
do (map=-map) ( a ll ) 
peakpi k 
from=map 
mpeak=&peak_num 
selection= ( all  
atom=true 
proximity= ( &atom_map ) 
end 
end 
write coo r output=$ filename select ion= ( s egid=PEAK ) end 
126 
Vita Matthew Alton Wilkerson is an East Tennessee native. He was born in Morristown, Tennessee on August 1 ,  1 977 to Dennis and Alta Wilkerson. He graduated from Morristown Hamblen County High School West in 1 995 . Afterwards he attended Carson Newman College where he received a B.A. in Biology. In 1 999, he was married to Karen Wilkerson. Also in 1 999, Matt entered the department of Biochemistry, Cellular, and Molecular Biology at the University of Tennessee. He graduated with a Masters of Science degree in December 2003. Matt is now a professor of Biology at Walter State Community College in his hometown of Morristown. · 128 
3872 2089. j8 ('J 
84/U/14 V .. f 
